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The respiratory epithelium is constantly exposed to oxidants both inhaled
and released by inflammatory leucocytes. A balance between oxidants and
anti-oxidants is critically important to the maintenance of normal cell
function. Cigarette smoke and ozone increase airspace epithelial
permeability. In this thesis I have investigated the hypothesis that this
phenomenon results from oxidant injury to the respiratory epithelium.
Respiratory epithelial permeability can be studied by the passage of
99mipc_[yppA from the lungs to blood. A wide range of normal values for
the time to 50% clearance (t50) has been quoted in the literature. I
compared an uncorrected and 2 background corrected methods of analysis
and their repeatability in 7 smokers (S) and 8 non-smokers (NS). No
difference in t50 values between the methods was found in S but the
uncorrected analysis gave higher values in NS. There was no difference
in the repeatability of the methods. Correction with an inter-renal
background region of interest was used thereafter as it allows the simple
and rapid analysis of any curve.
Fourteen smokers underwent 99mTc-DTPA lung scans after refraining
for 12 hours (chronic smoking, C) and after smoking until 1 hour before
study (acute smoking, A). 99nvpc_p)TPA clearance was increased in C and
further in A. Each smoker also underwent bronchoalveolar lavage (BAL)
after either C or A and seven control NS were also studied. Neutrophils
in BAL were increased in A. Superoxide release (02-~) from mixed BAL
leucocytes and plasma products of lipid peroxidation were increased in
both smoking groups. In BAL fluid (BALF) and epithelial lining fluid
(ELF) the latter doubled in C and increased 6 fold in A. Trolox equivalent
anti-oxidant capacity (TEAC) decreased in plasma and increased in BALF.
Reduced glutathione in the airspaces doubled in C. This increase was
abolished in A.
In a further study 15 healthy NS were exposed to filtered air (FA), or
ozone 100 or 400ppb for 1 hour, during intermittent exercise. Ozone
inhalation increased ELF volume overall. Neutrophils in BAL were
increased 6 hours after ozone 400ppb compared to FA. Ozone inhalation
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decreased C>2~ release from mixed BAL leucocytes and products of lipid
peroxidation in ELF, 1 and 6 hours after 400ppb. In vitro exposure of A549
cells to lOOOppb for 1 hour produced focal cell loss, with increased
intracellular protein mixed disulphides, export of oxidized glutathione,
and cytoskeletal disruption.
In conclusion increased epithelial permeability and neutrophil influx in
the airspaces, produced by oxidant inhalation are acute phenomena. In
smokers they were associated with increased oxidant stress. In healthy
non-smokers, in contrast, acute ozone inhalation was associated with
decreased oxidant stress, at least as measured by the extent of lipid
peroxidation and oxygen radical release from mixed BAL leucocytes, and
in addition anti-oxidant levels were maintained. In vitro studies
indicated the potential of ozone to increase oxidant stress in the




ABTS 2, 2'-azinobis (3-ethylbenzothrazoline-6-sulphonic
acid)
ai-Pi ai-proteinase inhibitor
(A)RDS (Adult) respiratory distress syndrome
BAL(F) Bronchoalveolar lavage (fluid)
BLPI Bronchial leucocyte protease inhibitor
BSA Bovine serum albumin
COHb Carboxyhaemoglobin
COPD Chronic obstructive pulmonary disease
SlCr-EDTA ^chromium labelled ethylenediamine tetra acetate
DTNB 5, 5'-dithionitrobenzoic acid
ELF Epithelial lining fluid
FA Filtered air
FBS Foetal bovine serum
FEVi Forced expiratory volume in one second
FITC-D Fluoroscein isothiocyanate dextran
fMLP N-formyl-L-methionyl-L-leucyl-phenylalanine
FVC Forced vital capacity
GBq Graybecquerels
G(M)-CSF Granulocyte (macrophage) colony stimulating factor
GPx/GR Glutathione peroxidase/reductase
GSD Geometric standard deviation
GSH/GSSG Reduced/oxidized glutathione
GST Glutathione-S-transferase
HIV Human immunodeficiency virus




113I-DTPA H3inciium labelled diethylenetriamine penta acetate
IL Interleukin (-1, -6, -8)
ILD/IPF Interstitial lung disease/Idiopathic pulmonary fibrosis
K2HPO4 di-potassium hydrogen phosphate
KH2PO4 Potassium di-hydrogen phosphate
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LH Polyunsaturated lipids




MMAD Mass median aerodynamic diameter
NaBH4 Sodium borohydride
NADPH Reduced nicotinamide-adenine dinucleotide
phosphate
NaHC03" Sodium bicarbonate
Na2HPC>4 Anhydrous di-sodium hydrogen phosphate
NaH2PO4.2H20 Sodium di-hydrogen orthophosphate dihydrate
NO/NO2/NOX Nitric oxide/Nitrogen dioxide/Oxides of nitrogen
OH- Hydroxyl radical
02*" Superoxide anion
PBS Phosphate buffered saline
PCP Pneumocystis carinii pneumonia
PDGF Platelet derived growth factor (-A, -B)
PMA Phorbol myristate acetate
ppb/ppm Parts per billion /million
PrSSG Protein mixed disulphides
ROI Reactive oxygen species
RTLF Respiratory tract lining fluid
SH Sulphydryl or thiol
SOD Superoxide dismutase
SSA Sulphosalicylic acid
t50 Time for lung activity to fall to 50%
99mTc_DTPA 99mtechnetium labelled DTPA
TBA(RS) Thiobarbituric acid (reactive substances)
TCA Trichloroacetic acid
TEAC Trolox equivalent anti-oxidant capacity
TLC Total lung capacity
TNF-a Tumour necrosis factor-a
TV Tidal volume
VE/I Expiratory/Inspiratory minute volume




1.1. THE LUNG AND THE ENVIRONMENT.
Galen said that without health, life is not life. This probably applies more
to respiratory disease than to any other system due to its chronic nature
resulting in distressing dyspnoea and limitation of exercise tolerance.
Respiratory conditions are the single largest cause of spells of certified
work incapacity, chronic obstructive pulmonary disease (COPD) having
the greatest impact on total working time lost (Lung and Asthma
Information Agency, 1992).
The greatest burden of respiratory disease is caused by cigarette smoking
with 110 000 related deaths per year in the U.K.. William Foege said at the
8th World Conference on Tobacco OR Health "Of all things that will
confuse historians of the next century, certainly the idea of a lethal
product, a product of illness and despair, peddled to youngsters for the
profit of the peddler, will be the most confusing." Cigarette smoking has
been causally linked to mortality from chronic bronchitis (Doll and Peto,
1976). Smoking was uncommon at the beginning of the century, but by
the end of the Second World War more than 80% of men and 40% of
women smoked. Smoking levels have declined in adults since then and
31% of men and 29% of women currently smoke cigarettes with the
highest levels being found in Scotland and the North of England (Lung
and Asthma Information Agency, 1993/1). However smoking levels in
teenagers aged 11-15 years have increased and between 1988 and 1991 rose
from 8-10% and among 15 year olds are already two-thirds of the adult
rate with 15% of boys smoking regularly and 25% of girls. Cigarette
smoking is increasing in the developing world and between 1970 and
1980 increased 33% in Africa and 24% in Latin America. Between 1960
and 1980 cigarette consumption rose by 400% in India and by 300% in
Papua New Guinea (Taylor, 1989).
In addition to the obvious effects of cigarette smoking there is now
increasing concern over the effect of environmental pollution on health
in general and respiratory disease in particular. Pollution is "the
contamination of outdoor or indoor air by one or more natural or man
made substances in such a way that the air becomes less acceptable for its
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intended use to maintain health" (Tattersfield, 1996). Potential respiratory
pollutants include ozone, sulphur dioxide, oxides of nitrogen, acid
aerosols and particles less than 10 and 2.5jum which are known as PMio
and PM2.5 respectively. The respiratory effects of pollution will depend
on the geography and climate and the type, nature and burden and
perhaps more importantly the combination of pollutants. Classical air
pollution was made up of smoke and sulphur dioxide and was associated
with the burning of coal and generally occurred in winter. Since the
1960s there has been a decrease in pollution from industrial sources and
domestic heating and an increase in pollution from motor vehicles. This
has resulted in the new problem of photochemical pollution of which
ozone is a constituent. Many pollutants are oxidants and their adverse
effects on the respiratory tract may be mediated through "oxidant stress".
Cigarette smoke contains 1C)16 free radicals per puff (Janoff et al., 1987) and
ozone is the second most powerful oxidant known.
Whilst public health measures aimed at reducing the prevalence of
cigarette smoking and at striking a compromise between society and
motor vehicles are required, the basic mechanisms of oxidant induced
lung injury require continuing investigation, particularly as there is
evidence of an increased oxidant burden in many respiratory conditions
(Taylor et al., 1986, Cross et al., 1994a).
1.2. THE RESPIRATORY TRACT.
The respiratory tract is divided into the upper and lower respiratory tract
which are defined as being above or below the cricoid cartilage. The lower
respiratory tract therefore includes the trachea and the bronchi and their
divisions. The trachea is lined with a mucous membrane of
pseudostratified ciliated columnar epithelium containing goblet cells.
The submucosa contains elastic fibres, a capillary plexus and mucous
glands. The trachea, main bronchi and lower lobe bronchi are outside the
substance of the lung. All other bronchi are situated within the lung. The
lower airways are known as bronchi as long as they contain any degree of
cartilage after which they become bronchioles. The final branches of these
conducting airways are the terminal bronchioles. Subsequent divisions
contain increasing numbers of alveoli in their walls and are known as
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respiratory bronchioles as they take part in gas exchange. They give off
alveolar ducts and alveoli. There are 8-13 subdivisions of bronchi. The
smallest bronchi are approximately 1mm in diameter with about 3-4
further subdivisions of bronchioles down to the terminal bronchioles.
There are usually 2 subdivisions of respiratory bronchioles each with
alveoli arising from its walls with 3-9 divisions into alveolar ducts which
are surrounded by alveoli. There are up to 9 generations of alveolar ducts.
The total number of alveoli has been estimated to be from 2-6x10^
(Burroughs and Edwards, 1960, Angus and Thurlbeck, 1972, Hansen and
Ampaya, 1976), thus giving the airways and airspaces a huge surface area
estimated to be 180cm2 at the level of the terminal bronchiole and 70-
80m2 at the alveolar level (Weibel, 1963).
The bronchial walls contain 3 layers, the mucosa, submucosa and
fibrocartilaginous layer which includes the smooth muscle. The mucosa
consists of pseudostratified squamous epithelium on an elastic lamina,
thinning distally and then merging with the alveolar epithelium. Most of
the mucosa is covered with groups of ciliated cells interspersed with non-
ciliated cells. There are 8 different cell types in the mucosa: the ciliated
cell, the goblet cell, the Clara cell, the serous cell, basal cells, intermediate
cells, brush cells and the endocrine or APUD (amine precursor uptake
and decarboxylation) cell. The submucosa is external to the basement
membrane and contains elastic fibres, mucous glands, smooth muscle,
nerves and lymphatics. The fibrocartilaginous layer continues from the
trachea to the smallest bronchus. As the cartilage becomes sparser the
fibrous layer thins and merges with the connective tissue of the lung and
the fibrous framework around the alveolar ducts. The fibrous layer is
pierced by nerves, blood vessels and mucous glands. Mast cells are found
in the submucosa and mucosa. Mucus is present over the bronchial
epithelium as a continuous sol layer, in which the cilia beat, and a gel
layer which is propelled over the surface.
The acinus is that part of the lung distal to the terminal bronchioles and
consists of respiratory bronchioles and their alveoli, alveolar ducts,
terminal alveolar sacs and alveoli. Alveolar sacs are hemispherical
structures the walls of which are composed of alveoli. There are
approximately 25 000 acini in the human lung. The walls of the
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respiratory bronchioles contain some muscle bundles diminishing
peripherally with some muscle fibres in alveolar ducts which are also
supported by collagen fibres, reticulin and elastin. The epithelium of the
respiratory bronchioles away from the alveolated portions is cuboidal and
contains the same cells as the more proximal airways with ciliated and
Clara cells being prominent.
The main functions of the respiratory tract epithelium are firstly to act as
a barrier against the diffusion of large molecules such as albumin into the
airways and airspaces and against inhaled material for example cigarette
smoke, pollutants such as ozone, bacteria, viruses and allergens, secondly
to maintain the composition and volume of the respiratory tract lining
fluids (RTLFs) and thirdly mucociliary clearance. These have been
described as the "target functions" of respiratory tract epithelial cells.
However an increasing role for airway and airspace epithelial cells as
"effector cells" has been described in the regulation of airway reflexes and
the maintenance of bronchodilatation and in immunological and
inflammatory responses including the production of nitric oxide (NO)
and endothelin-1, the expression of major histocompatibility class II
antigen expression and the production of arachidonic acid metabolites,
chemotactic agents and chemotactic factor inactivators and cytokines, for
example granulocyte macrophage and granulocyte-colony stimulating
factors (GM-CSF, G-CSF), interleukin-1 (IL-1), IL-6, IL-8, platelet derived
growth factor-A (PDGF-A) and PDGF-B (Dye and Adler, 1996).
The alveolar epithelium is a monolayer composed mainly of the very
thin type I pneumocyte and the more cuboidal type II pneumocyte (Figure
1.1). Each respiratory bronchiole is accompanied on one side by a
muscular pulmonary artery which gives off arteriolar branches which in
turn supply the alveolar capillaries. Each alveolus is surrounded by a
network of capillaries whose wall is one endothelial cell thick. The
alveolar capillary membrane thus consists of a single layer of alveolar
epithelial cells, their basement membrane, a thin interstitial space
normally between 5 and 10jum in diameter which may contain small
amounts of collagen and elastin, unmyelinated nerves and nerve
endings and occasional macrophages, the capillary basement membrane
and the capillary endothelial cells (Corrin, 1981). In many areas the
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Figure 1.1. Diagrammatic representation of the alveolar capillary
membrane.
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basement membranes become one eliminating the interstitium and
minimizing the distance for gas to diffuse from the alveolus to the
erythrocyte to about 0.2f/m at its narrowest. The alveolar capillaries join
together to form venules, alongside the respiratory bronchioles, which
join to form pulmonary veins which run in the interlobular septa.
Ventilation of alveoli may occur through collateral pathways as well as
directly down the bronchioles (Menkes and Traystman, 1977). Small
openings 10-15gm in size in alveolar walls, known as pores of Kohn
(Cordingley, 1972), permit the passage of gas between adjacent alveoli and
appear to become more numerous and larger throughout life (Macklem,
1971). In addition short epithelium-lined bronchiole-alveolar
communications about 30gm in diameter (Lambert, 1957) allow gas to
pass from one bronchiole to alveoli of a neighbouring acinus. Larger
diameter interbronchiolar communications may occur between adjacent
respiratory bronchioles (Martin, 1966) and collateral ventilation probably
also takes place at the level of alveolar ducts (Boyden, 1971).
Type I pneumocytes are specialized for the diffusion of gas from alveolus
to capillary. They are fewer in number than type II cells but their surface
area is much greater and so they cover the majority of the alveolar
surface. They contain endocytic vesicles which transport fluid, small
molecules such as large molecular weight proteins and dust particles
(Corrin, 1969). Type I cells are connected to each other by tight junctions.
They are derived from type II cells and do not undergo further division.
Type II cells have microvilli on their apical surface and tend to be
grouped in the corners of alveoli. They are rich in mitochondria,
endoplasmic reticulum and lamellar bodies which are secreted into the
alveolar lumen as surfactant. In acute alveolar injury type II cell
proliferation occurs with intermediate cells seen (Bowden, 1981).
Endothelial cells line the alveolar capillaries, are the most numerous
cells of the alveolar capillary membrane and are not connected by tight
junctions thus allowing small molecules and fluid to escape.
Alveolar macrophages are the main phagocytic cell of the acinus and are
derived from bone marrow promonocyte stem cells which enter the
circulation as monocytes and reach the lung by diapedesis through the
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capillary endothelium (Brody et ai, 1975). They can penetrate the alveolar
epithelium, probably mainly between type I and type II cells and come to
lie in the surfactant layer. They contain lysosomal bodies, phagosomes
containing particulate matter and whorled structures probably of ingested
surfactant. They secrete lysozyme, proteases, complement components,
plasmin inhibitors, alpha2 macroglobulin and chemotactic factors. They
also release oxidants and play an important immunological role.
Surfactant lines the inner surface of the alveolar epithelium and consists
mainly of dipalmitoyl lecithin and dipalmitoyl
phosphatidylethanolamine, combined with proteins. Surfactant is
positively charged and attaches to the negatively charged epithelium. It
decreases the surface tension of the alveolar wall during expiration and
thus reduces the work of inflation and also acts as a waterproofing
material (Hills, 1981, Hills, 1982). Surfactant greatly increases the pressure
required for fluid to leak from the interstitium into alveoli. In addition
any fluid which does leak tends to break up into droplets because of the
hydrophobic nature of surfactant and these will collect in the angles and
corners of alveoli where the surface tension generated may force them
back into the interstitium (Hills, 1982). Parasympathetic nerves from the
vagus carry afferent messages from stretch receptors within the lung,
from juxtacapillary J receptors and from bronchial irritant receptors
(Seaton et ah, 1989). Efferent parasympathetic fibres mediate
bronchoconstriction, bronchial gland secretion and probably pulmonary
vasodilatation (Nadel and Barnes, 1984). In addition the peptidergic or
non-adrenergic, non-cholinergic system exists. Its mediators are probably
peptides of which 2 seem particularly important, vasoactive intestinal
peptide and substance P (Barnes, 1984).
1.3.MACROPHAGES.
Alveolar macrophages are the major phagocytic cell in the airspaces and
are part of the reticuloendothelial system. They are derived from
circulating monocytes, bone marrow being the source of their common
precursors. These cells are involved in numerous homeostatic,
immunologic and inflammatory processes. Mature monocytes migrate
into tissues and body cavities where they differentiate into macrophages.
The majority of tissue macrophages are derived from monocytes.
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However there is evidence that a small percentage of macrophages derive
from local division of non-resident mononuclear phagocytes that have
arrived in tissues from the bone marrow before completion of cell
division. The percentage of alveolar macrophages synthesising DNA is
increased 10 times in inflammatory states and in smokers, from 0.5%
under normal conditions (Bitterman et al., 1984, Fels and Cohn, 1986)
when the macrophage population within tissues remains constant being
regularly renewed by the influx of monocytes (Van Furth, 1992).
Macrophages have diverse biological roles (Auger and Ross, 1992). In
their phagocytic capacity they provide an immediate defence against
foreign elements such as bacteria, viruses, fungi and protozoa prior to
leucocyte recruitment. Through phagocytosis and the production of
oxygen radicals and proteases, alveolar macrophages can eliminate most
particulates and micro-organisms from the distal airways and keep the
alveoli sterile. Phagocytosis involves the binding of a particle to the
surface of the phagocyte and subsequent engulfment of the bound
particle. Fc receptors and complement receptors enable macrophages to
recognise and phagocytose opsonised micro-organisms. Opsonisation of
bacteria with complement and/or IgG permits macrophage recognition
and subsequent phagocytosis of invading micro-organisms. Phagocytosis
can also occur without opsonisation if the micro-organism expresses
surface molecules that are directly recognised by the macrophage e.g.
carbohydrate residues. During phagocytosis alveolar macrophages and
other phagocytes release oxygen radicals and enzymes either into the
phagosome or the external environment. These are essential for bacterial
killing by phagocytes. Alveolar macrophages do not release as many
oxygen radicals as neutrophils but they outnumber them by up to 100 fold
or more in the airspaces (Greening and Lowrie, 1983). The site of
residence of the macrophage, the state of cell maturation and its state of
activation all govern the production of oxygen free radicals by
macrophages. Alveolar macrophages release more oxygen free radicals
than peritoneal macrophages, and peripheral blood monocytes, as they
mature, have a reduced capacity to release oxygen free radicals (Drath and
Karnovsky, 1975, Nakagawara et al., 1981). Macrophages also assist in cell-
mediated immune responses against pathogens, producing
immunomodulatory cytokines and regulating immunological responses.
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Phagocytosed antigen is processed and presented to lymphocytes in
conjunction with Class I or II molecules of the major histocompatibility
complex (Unanue and Allen, 1987) thereby stimulating antigen-specific T
cells.
Macrophages are a source of many important secretory substances
including cytokines and enzymes, cytokine and enzyme inhibitors,
growth factors, hormones, complement components, coagulation factors
and extracellular matrix proteins. Many of these secretory products are
induced by inflammatory or infectious stimuli and have roles in host
defence against tumours, secretory products inhibiting tumour cell
growth and leading to lysis of neoplastic cells (Adams and Hamilton,
1992).
Tissue macrophages are central to initiating the acute phase response.
Macrophages that have migrated to sites of inflammation have a large
and diverse potential for further development. Upon activation (Adams
and Hamilton, 1984, Paulnock, 1992), resident macrophages acquire
increased capabilities for killing of micro-organisms and tumour cells.
Activated macrophages also display maximal secretion of inflammatory
mediators such as tumour necrosis factor-a (TNF-a), prostaglandin E2
(PGE2), IL-1 and IL-6 which cause a secondary release of cytokines
including chemotactic factors for neutrophils e.g. IL-8 and monocytes e.g.
monocyte chemoattractant protein. During an inflammatory reaction,
there is increased recruitment of peripheral blood monocytes to the
perturbed site where they differentiate into macrophages. The transition
from monocyte to macrophage occurs over approximately 48 hours and
involves considerable increase in size, the number of cytoplasmic
organelles and surface molecules involved in effector function thereby
enhancing the potential capabilities of the differentiated cell.
Different types of macrophages occur in the lungs (Brain, 1988). The
alveolar macrophage is the best characterised and most extensively
studied and can be differentiated from the interstitial macrophage. It has a
lobulated nucleus and a vacuolated cytoplasm containing numerous
mitochondria and electron-dense secondary lysosomes (Pratt et al, 1971).
Alveolar macrophages are heterogeneous in morphology and function
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varying in size from 12 to 40jum (Cohen and Cline, 1971). Pulmonary
vascular macrophages have also been reported in humans adhering
tightly to the endothelial wall (Dehring and Wismar, 1989). Macrophages
are also present in large and small airways, some of which are alveolar
that have been carried up by the mucociliary escalator, and some of which
are resident cells of the airways, adhering tightly to the epithelial cells.
Membrane receptor expression and cell functions, such as phagocytosis
and mediator release, have been shown to vary among these different
subpopulations (Sibille and Reynolds, 1990). The distribution of
subpopulations differs between different disease states and each
subpopulation can respond differently to different stimuli.
Macrophages from smokers are larger (up to 50^m) and contain more
pigment indicating intracytoplasmic inclusions (Niewoehner et al., 1974,
Marcy and Merrill, 1987). They release increased amounts of oxygen
metabolites, such as superoxide anion (02*~), hydrogen peroxide (H2O2),
and hydroxyl radical (OH) (Hoidal et al., 1981). Release can be stimulated
by several activators including lectins, phorbol esters, N-formyl-L-
methionyl-L-leucyl-phenylalanine (fMLP), colchicine, arachidonic acid
and its metabolites, immune complexes, opsonised zymosan, y interferon
and TNF-a. The glutathione redox system is required for the respiratory
burst and membrane phospholipids are involved (Sibille and Reynolds,
1990). Alveolar macrophages are a rich source of the anti-oxidant
glutathione (Horton et al., 1987).
Proteolytic activity is a major function of alveolar macrophages. They
release a number of enzymes including lysozyme, particularly in
smokers, a serine elastase which is probably of neutrophil origin, a
metalloenzyme elastase, cathepsin L, collagenase (fibroblast like and type
V or gelatinase), ^-glucuronidase, acid hydrolases, plasminogen activator
and angiotensin converting enzyme (McGowan et al., 1983, Sibille and
Reynolds, 1990). They also release a number of anti-proteases including
al-antitrypsin, a2-macroglobulin, plasminogen activator inhibitor and
collagenase inhibitor (Sibille and Reynolds, 1990).
Alveolar macrophages can have both pro-inflammatory activities
through the release of activators in the airspaces and also anti-
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inflammatory activities through the release of different inhibitory
mediators. The balance between activators and inhibitors and the
mechanisms regulating their release is very important in determining
the outcome of lung injury.
1.4. NEUTROPHILS.
In most types of acute inflammation, in the lung as in other tissues, the
neutrophil predominates for the first 6-24 hours. The mature neutrophil
has a segmented nucleus with 2-5 lobes and several hundred cytoplasmic
granules containing principally lysozyme and lactoferrin with other
larger lysosomal granules containing myeloperoxidase, lysozyme, acid
hydrolases and a variety of other bacteriocidal proteins. The earliest
recognisable precursor is the myeloblast and with increasing maturation
there is increasing condensation and lobulation of the nucleus.
After their release from the bone marrow, neutrophils circulate in the
bloodstream with a half life of several hours. Within the bloodstream
there is a circulating and a marginated pool of approximately equal size.
The lung is a major reservoir for the marginated neutrophils. However
true margination in postcapillary venules may not occur in the lungs, the
"marginated" pool existing as sequestered cells in the pulmonary
capillaries (MacNee and Selby, 1993). It is presumed that all neutrophils
eventually leave the circulation either entering normal tissues at sites of
inflammation and not returning or being taken up as effete cells by the
reticuloendothelial system (Niewoehner, 1988). Cells are thought to leave
the bloodstream from the marginated compartment but can exchange
freely between the circulating and marginated pools during their brief
stay in the blood. Neutrophils migrate from the bloodstream by squeezing
between endothelial cells and penetrating the basement membrane.
During an acute inflammatory response there are alterations in local
blood flow and vascular permeability which facilitate the passage of
neutrophils into the area of inflammation.
The major function of neutrophils is phagocytosis, killing and digestion
of micro-organisms. Phagocytosis by neutrophils is greatly enhanced
when bacteria are coated with immunoglobulin or the C3b component of
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complement. The marginated pool can be rapidly recruited to sites of
inflammation in response to chemotactic factors. As with macrophages,
phagocytosis is associated with the respiratory burst through the
activation of a membrane-associated reduced nicotinamide-adenine
dinucleotide phosphate (NADPH) oxidase with the generation of oxygen
free radicals which are involved in bacterial killing. Neutrophils also
release various amounts of oxygen metabolites, including 02~, H2Q2, and
OH-, depending on the stimulus and on its concentration. The majority
of neutrophil enzymes are stored in the azurophilic granules. These
include acid hydrolases, myeloperoxidase, lysozyme, and neutral serine
proteases (Sibille and Reynolds, 1990). Among the neutral serine
proteases, neutrophil elastase represents quantitatively the major granule
component. It can degrade elastin, type I, II, III, and IV collagen,
fibrinogen, fibronectin, and proteoglycans. In addition, elastase as well as
the other neutrophil proteases (cathepsin G and collagenase) can activate
and inactivate C3 and C5a, thereby being involved in regulating the
inflammatory reaction.
As noted above all of these species can damage the lungs. Interactions
between bacteria, antibodies, neutrophils, and substances released by the
phagocytes themselves augment the inflammatory response and activate
the complement, kinin, coagulation, and fibrinolytic cascades. As a result,
specific chemotactic substances are generated which actively attract more
neutrophils to the site. Phagocytes are attracted to inflamed sites along a
"diffusion gradient" of inflammatory mediators and tissue breakdown
products. These events are closely followed by a marked increase in
marrow neutrophil production.
It has been reported in normal rabbit lungs that only about one alveolus
in 100 contains a neutrophil (Cohen et al., 1979). Their half-time for
disappearance from the bloodstream is 6 to 7 hours (Flenley et al., 1986).
As mentioned above sequestration of neutrophils occurs within the
pulmonary microvasculature. The average neutrophil has a mean
diameter of 7pim (range 5-8]Um), very similar to that of an erythrocyte but
larger than the pulmonary capillary lumen which has a mean diameter
of 5jUm (range 1-16/im) (MacNee and Selby, 1993). The deformability of
the neutrophil when negotiating the pulmonary microvasculature is
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therefore an important factor in its transit. Sequestration of circulating
neutrophils in the pulmonary microvasculature is increased by acute
cigarette smoking (MacNee et ah, 1989) due to decreased cell deformability
(Selby et ah, 1991, Drost et ah, 1993). Neutrophils accumulate in the
airspaces of cigarette smokers, the absolute number being consistently
raised (Hunninghake and Crystal, 1983, Nagai et ah, 1988, McCrea et ah,
1994). As mentioned above this may be mediated through the release of
chemotactic factors such as C5a, leukotriene B4 (LTB4) (Sibille and
Reynolds, 1990) and IL-8 (Kunkel et ah, 1991).
1.5. MEASUREMENT OF EPITHELIAL PERMEABILITY.
The alveolar-capillary membrane not only facilitates the exchange of gas
but also acts as a barrier against the diffusion of large molecules such as
albumin into the airspaces and against inhaled material for example
cigarette smoke, pollutants such as ozone, bacteria, viruses and allergens.
The tight junctions between type I cells are critical to this barrier function.
This barrier can be impaired, for example in fibrosing alveolitis or
alveolar oedema and by both cigarette smoke and ozone, producing
increased respiratory epithelial permeability (Jones et ah, 1980, Kehrl et
ah, 1987). The alveolar epithelium is thought to be approximately 10
times less permeable than the pulmonary capillary endothelium. It is
suggested that the pores in the alveolar epithelium are about 0.8-1.Onm in
radius whereas those on the capillary endothelium are about 4.0-8.Onm
(Taylor and Gaar, 1970).
The study of gas exchange is not a specific test of barrier function because
of the dominant effect of regional distribution of ventilation-perfusion
matching on gas exchange. The carbon monoxide diffusing capacity is
dominated by the magnitude of the surface area of the alveoli and by the
kinetics of the binding of carbon monoxide to haemoglobin and is not
particularly sensitive to changes in the functional properties of the barrier
itself (Jones et ah, 1983). Carbon monoxide, like other gases, readily
penetrates cellular membranes and is therefore insensitive to changes in
intercellular tight junctions. Closing volume has been used as an indirect
index of increased lung water which, if pulmonary vascular and colloid
osmotic pressures are normal, may reflect severely abnormal barrier
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function but it is of limited value in the study of subtle impairment
(Jones et al., 1983).
The simplest technique for the evaluation of the alveolar-capillary barrier
is to instill solutions containing indicators into the airways and to
measure them in the blood or alveolar fluid (Chinard et al., 1962). Enna
instilled drugs into the lungs of rats and after a certain time determined
drug concentrations in excised lungs thus calculating the half time of
absorption from the lung (Enna and Schanker, 1972). Iodinated
polyvinylpyrrolidone has been injected intravenously and recovered by
endobronchial washing (Valimaki et al., 1974). Radiolabeled tracer
molecules have been instilled into an isolated, saline filled lung segment
and both the saline and blood sampled at intervals (Nelson et al., 1978)
although concerns have been expressed that instillation of saline into
alveoli may itself produce epithelial permeability.
Early studies noticed that pulmonary oedema fluid obtained by deep
tracheal suction from ventilated patients with pulmonary oedema and
the sepsis syndrome had a protein content similar to that of plasma (Katz
et al., 1972, Robin et al., 1972). Although simple this technique as a
measure of barrier function did not achieve widespread clinical use
because the results are not always pathognomic, sequential oedema liquid
protein changes were not understood and oedema liquid often cannot be
sampled. The rate of appearance of radiolabelled albumin and other
tracers injected intravenously has been measured in suctioned
pulmonary secretions and bronchoalveolar lavage (BAL) (Sibbald et al.,
1981). In particular 131l-human serum albumin has been used in the
adult respiratory distress syndrome (ARDS) (Anderson et al., 1979) and
the albumin clearance calculated using the formula:
Albumin clearance into the bronchial tree (mis hr~l) = A x B
C
where; A = (E311j bronchial aspirate (counts ml'l)
B = bronchial aspirate volume (mis hr~l)
C = plasma [T31j] (COunts ml~l)
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This crude index was able nonetheless to detect a difference between
patients with left ventricular failure and those with sepsis and ARDS. It
assumes that the suctioned fluid sampled is representative of alveolar
fluid rather than inflammatory secretions from the bronchial circulation.
Studies employing multiple tracers instilled by aerosol have compared
the rate of appearance in serial blood samples of ^lchromium labelled
ethylenediamine tetra acetate (51Cr-EDTA) and 99mtechnetium labelled
diethylenetriamine pentacetate (99mpc_p)TpA) which are hydrophilic
with that of the lipid soluble 125]Landpyrine which is rapidly removed
from the lung. The chelates are very poorly diffusible across the normal
cell membrane and an accelerated clearance relative to antipyrine
indicates damage to the epithelial barrier. The index of permeability is
expressed as the ratio of the area under the chelate curve to that under
the antipyrine curve in the first 5 minutes after inhalation by bolus or
aerosol (Jones et ai, 1978, Huchon et ai, 1981). The drawbacks of this
technique are the need for 2 isotopes and the long half life of
therefore a search was made for a single tracer technique.
The requirement for a tracer molecule to study epithelial barrier function
is that it should be chemically inert, electrically neutral, hydrophilic and
highly stable and that it does not bind to specific sites on the cell
membrane nor is it actively transported across cell barriers. The labelled
chelates SICr-EDTA, "mTc-DTPA and 113indiUm labelled DTPA (113In-
DTPA) fulfill most of these requirements and have been used widely in
humans having, in particular, high in vivo stability (Jones et ah, 1983,
Hunter et al. 1990). In addition they approximate the molecular radius of
the pores in the alveolar epithelium and thus their passage will be a
measurement of the barrier function of the epithelium rather than the
capillary endothelium. The technique used should be easily applicable
and minimally invasive, y-emitters are preferred as they can be quickly
and easily measured.
The reference tracer was abandoned and 99mpc_[yypA increasingly used
as the radioaerosol although there are no data about whether it is
transferred by simple diffusion, facilitated diffusion, active transport or
vesicular transport although it is assumed to be the first of these. It is
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removed predominantly via the pulmonary circulation and <1% via the
lymphatics even in injured lungs when removal by the latter route is
increased (Rizk et al., 1984, Staub et al., 1990). 99mpc_p)TPA has a
molecular weight of 492 daltons with a radius of 0.6nm. An external
scintillation counter was initially used to measure the rate of
disappearance of the labelled chelate from the lung (Jones et al., 1980).
The rate of increase in activity in the leg following an intravenous bolus
of 99mrpc.p)XPA was measured with a second scintillation counter and
was used to correct for the increasing contribution from recirculating
background activity with time during a study. Other groups have used
only the first 7 or 10 minutes of the lung clearance curve extrapolating
the data beyond this, avoiding the portion of the curve affected by
recirculation and thus the need to use an intravenous correction
(Rinderknecht et al., 1980). Respiratory epithelial permeability may be
expressed as the time for 50% of the initial lung activity to disappear (t50)
or as the decline in activity min'l (k) derived from t50 = 0.693/k and
arbitrarily expressed as a percentage (klOO) (Barrowcliffe and Jones, 1987).
The site of deposition is an important factor. It is generally accepted that
to minimize tracheobronchial deposition there should be few particles
greater than 2jum in diameter. The optimal range for alveolar deposition
is between 0.3 and 2/im (Chan and Lippman, 1980). The permeability of
the conducting airways is less than that of the terminal airways, when
mucociliary clearance is taken into account, this slow clearance perhaps
being due to binding to mucus (Barrowcliffe et al., 1987). The clearance
rate is not influenced to any extent by variations in pulmonary blood
flow (Rizk et al., 1984). Raised lung volume and positive end expiratory
pressure both increase 99mpc_][)ppA lung clearance (Nolop, Maxwell et
al., 1986, Nolop, Braude et al„ 1987). Clearance is also increased in the
upper zones at least in the upright posture (Mason et al., 1983, O'Doherty
et al., 1985a, Dusser et al., 1986). Although cigarette smoking increases the
lung clearance of 99mrXc-DTTA (Jones et al., 1980) it is not affected by the
presence of COPD (Huchon et al., 1984) although the deposition of the
isotope is more central (Groth et al., 1990). It is important that the isotope
remains stable during the study and in this respect no accumulation in
the thyroid should be observed, this being the site for uptake of free
pertechnetate (Barrowcliffe and Jones, 1987). It has been shown with the
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more tightly bound H3mIn-DTPA, in comparison with ^mpcqyrpA,
that although some oxidative dissociation of the 99mrj,c_p),j'pA complex
may occur in a smoker's lungs it is not sufficient to explain the greater
clearance in smokers (Nolop et al., 1987). It is worth noting that clearance
is accelerated in smoking even although mucociliary clearance is slowed
(Lourenco et al., 1971). 99mpc_p)'ny\ lung clearance curves, derived from
studies of over 20 minutes, may be biphasic requiring 2 exponential
equations to fit all the data points. Biexponential 99mpc_p)ppA curves are
almost certainly abnormal. Even the very fast clearance times seen in
healthy smokers are always monoexponential (Hunter et al., 1990).
Biexponential curves are usually seen in acute lung injury (Barrowcliffe
and Jones, 1989).
In order to compare results among laboratories it has been recommended
that the following factors are reported (Staub et al., 1990):
1. The size of inhaled aerosol as mass median aerodynamic diameter
(MMAD) and its geometric standard deviation (GSD).
2. Ventilatory pattern used (tidal volume [TV] and ventilatory rate)
during the delivery of the inhaled 99rriTc-DTPA and the time required to
deliver the aerosol.
3. How the clearance was calculated from the recorded data, including
manner of selection of the initial data points and duration of counting.
4. Description of the data processing used to select the regions used for
counting.
5. Verification that the method of preparing 99mpc_p)-ppi\ ancj its
subsequent delivery did not cause dissociation of the 99mpc label from
the DTPA.
6. The method used, if any, to correct for accumulation of background
counts during measurement of clearance.
The main problem with the use of 99nvpc_p)XPA is its sensitivity, as seen
in healthy smokers, and changes in its clearance with changes in lung
volume. Staub and colleagues have suggested that molecules
intermediate in size between DTPA and albumin should be explored with
the goal of finding an agent more specific for lung injury and not
influenced by the above factors. However finding a better radioactive
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tracer has proved difficult because of incomplete binding,
intrapulmonary retention of the label and very slow clearance of larger
molecules such as albumin and transferrin (Staub et al., 1990).
The main technique for the investigation of pulmonary endothelial
barrier function is pulmonary lymph flow but this is not accessible in the
investigation of human patients or subjects (Jones et al., 1983). Other
methods have been used for example multiple arterial sampling after an
intravenous injection of a range of low molecular weight tracers,
allowing calculation of their transit time and distribution volume during
a single pass through the pulmonary vasculature, the results being
dependent on the distribution of pulmonary blood flow (Chinard et al.,
1962). The analysis of lung uptake of labelled urea can provide a useful
measure of increased capillary permeability (Brigham et al., 1979). Other
workers have studied the movement of radiolabeled protein from blood
to interstitium, for example injecting radiolabeled albumin and using a
gamma camera to calculate the ratio of activity over the lungs to that
over the heart (Sugarman et al., 1982). Alternatively in the protein
accumulation index, indium labelled transferrin (molecular weight 76
000) and technetium labelled red blood cells are injected, the latter as an
intravascular marker to correct for changes in blood volume in the fixed
field of view of a single scintillation detector over the lung (Gorin et al.,
1980). A modification of this technique uses a second scintillation counter
over the heart (Basran et al., 1985). 113min-transferrin is a diffusible
marker and the counts over the lung field provide a measure of
circulating and extravascular labelled transferrin. To correct for the
normal clearance of the radiotracer from the circulation and for decay the
lung counts are divided by those from the cardiac detector which
represents the blood pool. If this indium ratio remains constant then no
accumulation of protein has occurred in the lungs but if extravasation
into the lungs at a rate greater than lymphatic removal occurs, the ratio
increases with time. To correct for possible changes in thoracic blood
volume beneath the detector, the indium ratio is divided by an identical
ratio for technetium to give the lung transferrin index, the rate of change
of which provides the protein accumulation index. This index is
unaffected by smoking (Braude et al., 1986) but is increased in ARDS
(Rocker et al., 1987) even as soon as the criteria develop although there is
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overlap with the normal range (Braude et al., 1986). The protein
accumulation index is theoretically most sensitive in the first few
minutes after the intravascular injection of the tracer, as at early times
the influence of interstitial liquid volume and of losses in lymph or
otherwise are negligible. There is some doubt whether 113mjn_
transferrin is the best tracer as there are transferrin receptors on cells
particularly in inflamed tissue. Protein transport across endothelium
must be considered although there is little evidence that such pathways
play any significant role.
1.6. OXIDANTS AND ANTI-OXIDANTS.
An oxidant anti-oxidant imbalance in favour of oxidants or "oxidative
stress" may occur in a number of conditions affecting the lungs for
example oxygen toxicity, lung cancer, ischaemia-reperfusion injury and
lung transplantation, mineral dust pneumoconiosis, bleomycin and
paraquat toxicity, idiopathic pulmonary fibrosis (IPF), infant and adult
RDS, bronchopulmonary dysplasia, cystic fibrosis, immune complex
mediated lung injury, human immunodeficiency virus (HIV) associated
lung disease, asthma and acid aspiration (Cross et al., 1994a). The oxidant
anti-oxidant balance is critically important to the maintenance of normal
cell function. An imbalance has also been proposed in the lungs in COPD
(Taylor et al., 1986).
The lungs are constantly exposed to inhaled oxidants, for example
cigarette smoke, ozone, nitrogen dioxide and sulphur dioxide, and those
released from inflammatory leucocytes. Cigarette smoke is the main
aetiological agent in COPD and contains 10^6 free radicals per puff (Janoff
et al., 1987). The elevated numbers of inflammatory cells in the
parenchyma and airspaces of the lungs in smokers are primed to release
increased amounts of oxidant species (Hoidal et al., 1981). This may also
be true of those sequestered in the pulmonary microvasculature (Brown
et al., 1995). Phagocytes, that is macrophages and neutrophils, produce not
only OH-, 02-~ and H2O2, as mentioned earlier, but also hypochlorous
acid (HOC1) and other oxidative products (Cross et al., 1994b). A further
powerful oxidant species, peroxynitrite, may be produced by the reaction
of 02-" and NO when levels of both are increased. Under normal
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conditions NO acts as an anti-oxidant by quenching C>2~ (Cross et al.,
1994a). Transition metal ions or oxygen radicals and thiols may also
interact producing reactive and potentially toxic thiyl or oxysulphur
radicals (Munday, 1989, Huston et al., 1992, Korge and Campbell, 1993).
Oxidant actions may also be mediated by products of reactions between
inhaled toxins and the RTLF's (Cross et al., 1994b).
Direct measurement of free radical activity is technically difficult. Most
investigators rely on indirect measurements, for example, the extent of
lipid peroxidation, overall anti-oxidant capacity or evidence of oxidative
damage to proteins and DNA. Oxygen radicals generated close to a cell
membrane oxidise membrane phospholipids resulting in lipid
peroxidation, a process which may continue in a chain reaction. Several
methods exist for the determination of the extent of lipid peroxidation in
biological samples although none are specific (Petruska et al., 1990). They
include measurement of lipid hydroperoxides by titration with iodine
release, stimulation of PGH synthase activity or luminol-enhanced
chemiluminescence. Other techniques rely on the measurement of
products formed during lipid peroxidation. Conjugated dienes, which
absorb ultraviolet (UV) light in the range 230-235nm are formed
immediately following initiation of lipid peroxidation. Using gas-liquid
chromatography, expiration of ethane and pentane, gases commonly
generated during lipid peroxidation, may be quantified in vivo. Another
technique involves the measurement of fluorescent products which are
produced when dialdehydes, one of many types of products of lipid
peroxidation, react with amino groups of proteins, phospholipids or
nucleic acids to yield Schiff bases. The most popular method of lipid
peroxide detection is the thiobarbituric acid reactive substances (TBARS)
test. Malondialdehyde (MDA) is produced by free radical attack on
polyunsaturated fatty acids in cell membranes. It can be complexed with 2
molecules of thiobarbituric acid (TBA) to yield an adduct with maximum
absorption at 532nm. The MDA-TBA adduct can be measured
fluorometrically (Yagi, 1976) or by high pressure liquid chromatography
(HPLC) (Petruska et al., 1990).
Anti-oxidants in the RTLF's, mucus and epithelial lining fluid (ELF),
provide the first line of defence against oxidant stress. They include
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mucin, ascorbic acid, the lipid soluble a-tocopherol, reduced glutathione
(GSH) and the enzymes of its redox cycle for example glutathione
reductase (GR) and glutathione peroxidase (GPX), uric acid, the metal
binding proteins caeruloplasmin, transferrin, and lactoferrin, the anti¬
oxidant enzymes superoxide dismutase (SOD) and catalase, sacrificial
proteins particularly albumin and unsaturated lipids (Cross et al., 1994b).
The anti-oxidants present in greatest molar concentrations in ELF are
GSH (100-400juM), ascorbic acid (100/zM), uric acid (90f/M) and albumin-
thiol (albumin-SH) (70fiM) (Cantin et al., 1987, Cross et al., 1994b).
The thiol anti-oxidant GSH is one of the most important anti-oxidants in
the lungs. It is a tripeptide, y-glutamyl-cysteinyl-glycine. It is present in
approximately 100 fold greater concentrations in ELF than in plasma
(Cantin et al., 1987) and is also an important intracellular anti-oxidant in
lung cells. Both intra- and extracellular GSH are depleted by oxidants. The
source of GSH in ELF is thought to be the epithelial cell but this remains
uncertain (Heffner and Repine, 1989). Macrophages also contain high
levels of intracellular GSH (Horton et al., 1987). Thiols such as N-acetyl
cysteine and GSH are able to scavenge OH-, H2O2 and HOC1 (Aruoma e t
al., 1989). Other thiol anti-oxidants include protein-SH groups, for
example in albumin, and mucin (Cross et al., 1994a). Albumin contributes
43% of the Trolox equivalent anti-oxidant capacity (TEAC) in plasma
(Miller et al., 1993) and has 1 SH group per molecule. It may form
albumin-thiyl radicals or albumin-SH group conjugates with
electrophiles present in cigarette smoke (Rahman and MacNee, 1996).
Ascorbic acid is an important water soluble extracellular anti-oxidant,
sparing other anti-oxidants, such as a-tocopherol, through its recycling,
and by scavenging toxic free radical products (Frei et al., 1990). Uric acid is
secreted by the same upper airway epithelial cells that secrete mucin and
a-tocopherol and by type II alveolar epithelial cells along with surfactant
(Peden et al., 1993, Rustow et al., 1993). It is a major low molecular weight
anti-oxidant present in the lining fluids of the upper respiratory tract
(Peden et al., 1993). It appears to be the most important scavenger of
ozone in plasma contributing 33% of the TEAC and may also be
important in the respiratory tract (Cross et al., 1992).
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There are technical difficulties in studying anti-oxidants in ELF and in
epithelial cells. Both are normally obtained by BAL. This technique
involves the instillation of an aliquot or aliquots of warmed normal
saline into a segment of the lung followed by its aspiration.
Approximately 50-60% is normally recovered. It results in the dilution of
ELF by a factor which may not only be uncertain but also variable, both
from BAL to BAL and between operators and with regard to the different
anti-oxidants under study (European Society of Pneumology Task Group
on BAL, 1989). A correction is therefore necessary for this dilution, the
most satisfactory being the albumin (Ward et al., 1993) and the urea
methods (Rennard et al., 1986). Certain anti-oxidants are found in greater
concentration in ELF than in plasma most notably GSH and ascorbic acid.
The reason for this apparent concentration of GSH in ELF compared to
plasma is not known (Cantin et al., 1987). Uric acid and albumin-SH
levels are lower in ELF than in plasma (Cross et ai., 1994b).
It has been proposed that certain oxidants, ozone for example, may not
penetrate the surface layer of mucus or ELF (Pryor, 1992). Nonetheless
plasma anti-oxidants are also important in protecting the lungs. Oxidant
injury to the respiratory tract results in neurogenic inflammation,
involving endothelial permeability and epithelial "leak", resulting in the
transudation of plasma anti-oxidants into the interstitium and then into
mucus and ELF (Persson ei ul., 1991, Cross et al., 1994b) perhaps increasing
the total anti-oxidant capacity of the RTLF s. This transudation may be
the result of direct activation or injury of the cells of the respiratory
epithelium or may result from the activation of neurohumoral mediator
pathways.
The effectiveness of anti-oxidant protection in RTLF will depend on the
type of anti-oxidants present, their concentration and the depth and
surface area of the lining layer. Protection of both constituents of the
lining fluid itself and the underlying epithelial cells and interstitium
presumably results (Cross et al., 1994b).
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1.7. SMOKING AND CHRONIC OBSTRUCTIVE PULMONARY
DISEASE.
Smoking is the most important cause of chronic bronchitis and
emphysema or COPD (U.S. Department of Health and Human Services,
1984). Having been introduced to the Old World by Sir Walter Raleigh,
the health effects of smoking were recognised by King James VI of
Scotland and I of England. It is 200 years since Samuel Johnson's lungs
became the first recorded case of emphysema and Charles Badham coined
the term "chronic bronchitis". In 1834 Laennec made the observation that
"in emphysema the air makes its escape from the air cells much slower
than in a healthy state of the organ. This seems to indicate either more
difficult communication between air contained in the air cells and that of
the bronchi, or else diminished elasticity of the air cells themselves... both
causes conspire to produce the effect in question" (Laennec, 1846). In 1870
Sigmund reported that heavy smokers suffered "affections" of the nose,
mouth and throat more frequently than non-smokers and in a more
virulent fashion. In 1897, Mendelssohn reported the incidence of
"affections" of the respiratory tract to be 60% greater in smokers than in
non-smokers, as well as somewhat greater in those who inhaled
compared with smokers who did not inhale. Since then the incidence of
COPD has increased dramatically and recently particularly in women.
The most important evidence linking smoking and mortality from
chronic bronchitis comes from the study of doctors which found that the
death rate was significantly higher in cigarette smokers than in non-
smokers and increased with the amount smoked (Doll and Peto, 1976).
Chronic bronchitis is defined by "the production of sputum on most days
during at least 3 consecutive months in 2 successive years" (Medical
Research Council, 1965). Emphysema is defined by the National Heart
Lung and Blood Institute in the U.S. as "a condition of the lung
characterized by abnormal, permanent enlargement of airspaces distal to
the terminal bronchiole, accompanied by the destruction of their walls,
and without obvious fibrosis" (Snider et al., 1985). COPD is defined as
"abnormal values in tests of expiratory flow, which have not changed
substantially over several months and which are not related to specific
causes of airflow obstruction" (American Thoracic Society, 1987).
Approximately 80-90% of deaths from COPD are attributable to smoking
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(U.S. Department of Health and Human Services, 1984). In the late 1980s,
in the U.K., the prevalence of chronic bronchitis was 15-20% in middle
aged men and about 8% for middle aged women (Strachan, 1995). In 1986
71 099 people died as a result of COPD in the U.S., a 33% increase from
1979. The mortality was 1.8 fold greater in men than women and 2.8 fold
greater in whites than blacks. The incidence of chronic bronchitis in 1980
was 36.1 per 1000 and emphysema 11.4 per 1000 (Stratton and NTUabe,
1990).
In 1963, Laurell and Eriksson observed that subjects whose serum was
deficient in ai-antitrypsin (ai-AT) [ai-proteinase inhibitor (ai-Pi)] were
more likely to develop emphysema than normal subjects (Laurell and
Eriksson, 1963). Gross subsequently showed that papain could produce
emphysema when instilled into the trachea of experimental animals
(Gross et al., 1979). From these original observations the protease-anti-
protease theory of the pathogenesis of emphysema developed which in
its simplified form states that cigarette smoke attracts alveolar
macrophages to accumulate around the terminal bronchioles, the site of
development of centrilobular emphysema (Niewoehner et al., 1974).
They release chemotactic factors which attract neutrophils to this site
from the circulation (Hunninghake et al., 1980). The neutrophils then
release human neutrophil elastase (HNE) which can attack the lung
interstitial matrix particularly elastin. HNE binds covalently to ai-AT
and is inactivated, thus forming a very effective defence for the lung
against attack by HNE. Disturbance of this protease-anti-protease balance
is thought to be important in the pathogenesis of emphysema (Idell and
Cohen, 1983). This can be caused by cigarette smoke and reactive oxygen
intermediates released from neutrophils which can oxidize the critical
methionine residue at position 358 in ai-AT, which is the active site for
interaction with HNE, producing inactivation of ai-AT (Gadek et al.,
1979, Carp et al., 1982). The evidence that this occurs in vivo in humans is
controversial (Gadek et al., 1979). However elevated levels of elastin
derived peptides have been found in the blood of smokers, levels being
more elevated in those with severe airflow limitation suggesting the
presence of an enhanced elastase burden (Kucich et al., 1985). Other
antiproteases may also have a protective role in emphysema for example
anti-leucoprotease (Kramps et al., 1988). Human alveolar macrophages
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also attack elastin. They can bind human neutrophil elastase and
incorporate it intracellularly with subsequent release of the enzyme in an
active form (McGowan et al., 1983). They also secrete a cysteine protease
and may also secrete a metal dependent proteinase (Flenley 1986). The
total number of inflammatory cells and the number of neutrophils in the
airspaces of smokers are increased (Hunninghake and Crystal, 1983,
Martin et al., 1985, Koyama et al., 1991). They show increased oxidative
metabolic responses (Hoidal et al., 1981) and enhanced cytotoxic potential
(Davis et al., 1988). Long-term cigarette smoking also increases the
number of neutrophils in the peripheral circulation and in lung
parenchyma (Niewoehner, 1988, McGowan and Hunninghake, 1989).
Acute cigarette smoking has been shown to cause the sequestration of
neutrophils to the pulmonary vasculature (MacNee et al., 1989). Once
sequestered their subsequent migration into the airspaces may be
mediated through the release of chemotactic factors such as C5a, LTB4
(Sibille et al., 1990) and IL-8 (Kunkel et al., 1991).
1.8. OZONE.
Urban air pollution was a major problem in the U.K. until after the
turning point of the infamous London fog of December 1952 (Ministry of
Health, 1954). Such pollution resulted mainly from the burning of coal
for domestic and industrial purposes. The Clean Air Act of 1956 was
introduced following this and since then there has been a major decrease
in the levels of smoke and sulphur dioxide to acceptable levels.
Ozone or O3 is the main constituent of photochemical pollution. It is
otherwise found in the "ozone layer" in the stratosphere between 20 and
50km above the surface of the Earth. Its name is derived from the Greek
"ozein", which means "to smell", since it has a characteristic odour
which defies description.
The structure of ozone is represented as a resonance hybrid of 2
equivalent Lewis formulae (Figure 1.2). It is commonly prepared by
allowing a low temperature electric discharge or UV radiation to pass
through O2:
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Figure 1.2. The structure of ozone is represented as a resonance hybrid of
2 equivalent Lewis formulae.
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302(g) ► 203(g)
At room temperature ozone tends to decompose on standing as follows:
203(g) ► 302(g)
Ozone is the most important trace constituent in the stratosphere, which
is a stable cloudless region, with little vertical circulation and is formed
thus:
02 ^ UV radiation ^ 2O (i)
O +O2 + M ► O3 + M (ii)
M is a third body such as an oxygen, nitrogen or other molecule present
in the atmosphere which must be present to take up part of the energy
otherwise the ozone molecule would probably decompose rapidly. By
doubling (ii) and adding it to (i) the overall reaction is obtained:
302 ► 203
Because this reaction is initiated by radiant energy it is called a
photochemical reaction. Most of the ozone is produced over the tropics in
the upper stratosphere between 25 and 35km. However due to movement
the highest concentrations are found over the polar regions at about
15km. Ozone in this layer protects us from the harmful effects of UV light
and is therefore extremely desirable. The ozone molecules absorb UV
radiation thus:
03 ^ UV radiation ^ O2 + O
Almost all of the O atoms formed then recombine, to form ozone7 as
above in (ii). In recent years the ozone content of the ozone layer has
decreased over the South Pole producing a "hole" which has been
extending alarmingly.
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Ozone is also found at ground level in the troposphere where the
background level is normally 25-35 parts per billion (ppb). This is only 2-3
fold less than the level which is generally accepted to be associated with
adverse health effects. Eighty per cent of ground level ozone is formed in
the troposhere and 20% originates in the stratosphere (Hough and
Derwent, 1990). In the U.S., standards recommend that ground level
ozone does not exceed 0.12 parts per million (ppm) for 1 hour on more
than 1 occasion in each year. This standard is exceeded for 60% of the U.S.
population. In California the standard is tighter, the level being O.lOppm.
The World Health Organisation recommend that the ozone level should
not exceed 76-100ppb for 1 hour or 50-60ppb for 8 hours (World Health
Organisation, 1987). This is exceeded by all the rural monitoring sites in
the U.K. each year except remote sites in ozone poor years. Ground level
ozone tends to be lower in urban areas than in the suburban and rural
areas adjacent, due to destruction by NO emitted by motor vehicles and
other combustion sources. In Los Angeles ozone levels reach 300-400ppb
and in 1977 and 1978 there were 20-30 days and 60-75 days respectively
where the level was greater than 200ppb. The highest levels in the U.K.
were recorded during the long hot summer of 1976, 258ppb being
recorded in Oxfordshire (United Kingdom Photochemical Oxidants
Review Group, 1987) and, in 1990, 161ppb at Lullington Heath.
Ozone production in the troposphere depends on volatile organic
compounds (VOC's), sunlight and low wind speed. VOC's react with
oxides of nitrogen (NOx) as follows:
N2 + O2 ► 2NO
2N0 + 02 ► 2N02
NO2 ^ UV radiation ^ NO + O (Photochemical
decomposition)
The atomic oxygen formed is extremely reactive:
O +O2 + M ► O3 + M
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After ozone is formed it can react with more NO to produce N02'
NO + O3 ► NO2 + O2
For every molecule of NO2 delivered to the atmosphere a molecule of
ozone may be formed. The overall reaction is given below;
NOx + VOC UV_^ ^
VOC's are derived from solvent use and industrial processes (51%) and
motor vehicles (37%) and NO\ from motor vehicles also (48%) and
power stations (29%). There are no direct emission sources of ozone.
Normal subjects show a wide range of sensitivities to ozone, the effects
being increased by exercise and the duration of exposure, at least up to
several hours (Horstman et al., 1990). In healthy subjects and in those
with pre-existing disease environmental levels of ozone may produce
symptoms and a decrease in lung function which is reversible and short
lived. There is no threshold for the effects of ozone.
There has been a doubling in ozone concentrations since 1900 although
measurements did not generally began until 1971. There is now a
network of monitoring stations in the U.K., established in 1987 following
a review of U.K. ozone data by the Department of the Environment's
Photochemical Oxidants Review Group, co-ordinated by Warren Spring
Laboratory (United Kingdom Photochemical Oxidants Review Group,
1987). There has been no general increase in ozone levels since 1971
(Lung and Asthma Information Agency, 1993/5).
The main sink for ozone is dry deposition at the ground particularly on
leafy foliage. This explains why the highest levels in Scotland are found
on the tops of the Cairngorm mountains where foliage is sparse and
heather plentiful. The highest levels in the U.K. occur between April and
September, each "ozone episode" lasting on average between 1 and 5
hours with gaps between of 20 hours. Ozone build up is cumulative, over
episodes which are generally of 1-5 days duration, with levels falling at
night as air cools and falls to the level of the foliage. Levels are highest on
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the South Coast there being 5-10 times the number of hours where the
level exceeds 60ppb than in the North of Scotland. There are 100-200
hours each year where the level exceeds this and 10-50 hours annually
where it exceeds lOOppb (United Kingdom Photochemical Oxidants
Review Group, 1987). Levels tend to be highest in the mid to late
afternoon.
Approximately 40% of ozone is taken up in the nasopharynx and 60% in
the lower respiratory tract (Gerrity and Weister, 1987). There is essentially
complete absorption at the beginning of the proximal alveolar region (Hu
et al., 1992). In rats prolonged ozone exposure produces a loss of cilia from
ciliated cells and spreading of Clara cells on the basement membrane
surface with a decrease in luminal surface area (Barry et al., 1988). An
increase in the volume of type I and type II cells occurs and this is related
to total exposure (Chang et al,. 1991).
Ozone may cause cough, shortness of breath and chest pain on
inspiration. The dose is a product of the ozone concentration, duration of
exposure and minute ventilation, the most important being the
concentration. Ozone causes certain changes in lung function. Forced
expiratory volume in one second (FEVi), vital capacity (VC) and total
lung capacity (TLC) are reduced with no change in residual volume or
functional residual capacity. The fall in VC is usually almost as great as
the fall in FEVi. There is a close relationship between ozone dose and
both FEVi and VC especially if any fall is expressed as a percentage. An
increase in airway resistance and specific airway resistance occurs. There
is no change in static or dynamic lung compliance but lung volume is
reduced at any given static lung recoil pressure. Maximum static lung
recoil pressure is reduced. There is no change in maximum inspiratory or
expiratory mouth pressures. Respiratory rate (RR) increases and TV
decreases. Respiratory epithelial permeability to 99m'jc_p)'ppi\ increases
(Kehrl et al., 1987). Exercise capacity decreases and bronchial
responsiveness increases (Schelegle and Adams, 1986, Hazucha, 1987,
Hazucha et al., 1989). Most studies have shown an increase in the
response to allergen following ozone exposure (Yanai et al., 1990, Molfino
et al., 1991). The effects of ozone on lung function generally resolve after
24 hours (Folinsbee and Hazucha, 1989, McDonnell et al., 1985). With
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continued exposure the effects are maximal at 2 days and minimal at 5
days with adaptation lasting 7-20 days (Horvath et al., 1981).
The mechanism of the effects of ozone on lung function is not well
understood. The reduction in VC and TLC may be due to involuntary
inhibition of full inspiration by stimulation of non-myelinated C-fibres
possibly by prostaglandins released during airway inflammation
(Hazucha et al., 1989). Although bronchoconstriction occurs it is much
less than is seen with conventional bronchoconstrictor agents relative to
symptoms and the fall in VC. There is a wide variability in response to
ozone between subjects (Horstman et al., 1990, Weinmann et al., 1995).
The change in FEVi is not related to baseline FEVi nor to bronchial
responsiveness (Folinsbee et al., 1988). The effects may be greater in young
women than young men (Messineo and Adams, 1990, Aris et al., 1995).
Smokers may be less responsive to ozone (Shephard et al., 1983, Kagawa
1984). One chamber study has suggested that asthmatics may be more
responsive (Kreit et al,. 1989). In patients with COPD no changes in FEVi
or VC have been seen following exposure of up to 200ppb for 2 hours but
the total ozone dose received is low in such subjects due to their limited
exercise ability (Solic et al., 1982, Linn et al., 1983). The elderly may be less
responsive (Drechsler-Parks et al., 1987) and black adults more responsive
than white adults. Whilst it has been said that the changes in lung
function are no different in "at risk" groups it has been concluded by the
Advisory Group on the Medical Aspects of Air Pollution Episodes that
there are relatively few studies comparing at risk groups with most being
poorly controlled or with insufficient numbers (Department of Health,
1991).
The public health effects of ozone have been studied. There appears to be
no association between symptoms and the ambient ozone level. It has
been concluded that pollution, of which ozone is a part, may produce a
small increase in asthma morbidity and utilisation of medical services.
An individual contribution for ozone cannot be identified. In public
health studies asthmatics appear to show the same sensitivity to ozone as
non-asthmatics. The Advisory Group states that it seems unlikely that
ozone explains the epidemic pattern of asthma observed in various parts
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of the world (Department of Health, 1991). They also state that it seems
unlikely that ozone can explain the seasonal periodicity of asthma
although a modifying effect is not ruled out. Peak ozone levels occur in
May, June and July (Bower et al., 1991). Asthma mortality is highest in
August and hospital admissions in September (Khot and Burn, 1984,
Khot et al., 1984). The prevalence and severity of asthma have increased
in the U.K. in the past 20-30 years (Burr, 1987) but there has been a long
term reduction in ozone levels at 3 sites in south east England (Bower et
al., 1991). In the summer of 1976 in the U.K. when ozone levels were
increased markedly for several weeks there was no increase in asthma
related mortality (Khot and Burn, 1984, Khot et al., 1984). Supporting
evidence comes from Ontario where between 1974 and 1983 there was an
increase in asthma admissions but no clear trend in ozone levels (Bates
and Sizto, 1987). The Advisory Group comments that there is a general
lack of data on trends in ozone with which to test the hypothesis that it is
associated with the increase in asthma (Department of Health, 1991).
1.9. AIMS.
The aim of this thesis is to investigate the effects of cigarette smoke and
ozone on the respiratory epithelium. Initial studies compared 3 methods
of 99nvpc_[yppA clearance from the lungs to blood as a measure of
airspace epithelial permeability and assessed their repeatability. Both
cigarette smoke and ozone have been shown to increase airspace
epithelial permeability (Jones et al., 1980, Kehrl et al., 1987). The effect of
cigarette smoking occurs within 3 days of starting smoking (Minty et al.,
1984) and is rapidly reversible on stopping (Minty et al., 1981, Mason et al.,
1983). Controlled studies of the acute effects of cigarette smoking on
airspace epithelial permeability have not previously been performed
however. Cigarette smoke contains 10^6 free radicals per puff (Janoff et
al., 1987) and thus ozone inhalation was used as a model for acute oxidant
effects on the normal respiratory tract. Using a background corrected
method of 99mpc_fyppj«\ iung clearance, employing an inter-renal region
of interest, further studies of airspace epithelial permeability were
performed in chronic cigarette smokers following acute smoking and in
normal volunteers following exposure to ozone at environmentally
relevant levels. Neutrophils accumulate in the airspaces of cigarette
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smokers (Hunninghake and Crystal, 1983, Nagai et at., 1988, McCrea et at.,
1994) and increased levels of the anti-oxidant GSH are found in their ELF
(Cantin et at., 1987). Ozone also produces an influx of neutrophils into the
airspaces of normal non-smokers (Koren et at., 1989, Devlin et at., 1991,
Koren et at., 1991, Schelegle et at., 1991). BAL was therefore performed to
investigate the effect of acute cigarette smoking in chronic smokers and
ozone exposure in healthy volunteers on the percentage and number of
neutrophils and oxidant status in the airspaces. Previous studies have
suggested a role for the cytoskeleton in maintaining the integrity of the
respiratory epithelium (Bhalla et at., 1990, Yu et at., 1994). In vitro studies
of ozone exposure on the integrity of the respiratory epithelium, oxidant
status and the cytoskeleton were thus performed.
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CHAPTER 2. MATERIALS AND METHODS.
2.1. MATERIALS.
2.1.1. Reagents.
5-sulphosalicylic acid, cytochrome c, triethanolamine, 5, 5'-
dithionitrobenzoic acid, glutathione reductase, nicotinamide-adenine
dinucleotide phosphate reduced form, glutathione reduced form and
oxidised form, bovine serum albumin, phorbol myristate acetate,
superoxide dismutase, hydrogen peroxide, thiobarbituric acid, 1, 1, 3, 3,-
tetramethoxypropane, myoglobin type III, potassium ferricyanide, 2, 2'-
azinobis (3-ethylbenzothrazoline-6-sulphonic acid), trichloroacetic acid
and EDTA-Na2 were obtained from the Sigma Chemical Co., Poole,
England.
Dulbecco's phosphate buffered saline was obtained from Gibco BRL,
Paisley, Scotland and neutralised to pH 7.4. Eagle's minimal essential
medium, foetal bovine serum, L-glutamine, sodium bicarbonate, trypsin-
EDTA 10%, 10mm Nunc tissue culture treated inserts and Nunc single
chamber glass slides were also from Gibco.
Trolox (6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-carbansaeure), 2-vinyl
pyridine and sodium borohydride were supplied by Hoffman-la Roche,
Aldrich Chemical Co., Dorset, England.
Potassium di-hydrogen phosphate, di-potassium hydrogen phosphate,
sodium di-hydrogen orthophosphate dihydrate, di-sodium hydrogen
phosphate anhydrous, acetonitrile, dextrose, phosphoric acid, 60%
perchloric acid, n-butanol and conical tubes were supplied by BDH,
Dorset, England.
99mTc_DTPA was prepared from sodium pertechnetate injection
obtained from an Amertec II generator (Code MCC20) and a Pentetate II
kit (Code N108) both supplied by Amersham International, Aylesbury,
England. Sodium 125ic>chcle was also from Amersham.
Cyclimorph, atropine, lignocaine, normal saline and medical grade 02
and air were obtained from the hospital pharmacy. Medical grade 95% air
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and 5% CO2 was obtained from the British Oxygen Company, Glasgow,
Scotland. Benzylpenicillin was supplied by Britannia Pharmaceuticals
Ltd., Redhill, Surrey, England and streptomycin by Evans Medical Ltd.,
Horsham, West Sussex, England. Diff Quik was supplied by Merz Dade,
Switzerland. Purafil was supplied by the Purafil Corporation, Sutton
Coldfield, England. The A549 cells are a type II alveolar epithelial
adenocarcinoma cell line (ECACC No. 86012804) and are maintained in
continuous culture in the Rayne laboratory. 20% normal rabbit serum
was supplied by the Scottish Antibody Production Unit, Lanarkshire,
Scotland. Rhodamine-conjugated phalloidin was obtained from
Cambridge Bioscience, Cambridge, England. The PD-10 Sephadex column
G-25M was obtained from Pharmacia Biotech Ltd., Milton Keynes,
England. 96 well microtitre plates were supplied by Greiner, Dursley,
England. 75ml tissue culture flasks were obtained from Falcon, NJ,
U.S.A.. 30mm plastic petri dishes were obtained from Becton Dickinson,
Plymouth, England. 0.2jum membranes were supplied by Millipore,
Milton Keynes, U.K.. Dialysis tubing was obtained from Medicell Int Ltd.,
Liverpool, England.
2.2. SPIROMETRY.
FEVi and forced vital capacity (FVC) were both performed on a dry
spirometer supplied by Vitalograph Ltd., Buckingham, England. The best
of 3 attempts was recorded and reproducibility maintained by ensuring
that there was no more than lOOmls between the best 2 of each.
2.3. CARBOXYHAEMOGLOBIN.
Ten mis of venous blood was taken into a lithium heparin tube for
carboxyhaemoglobin (COHb) measurement on an IT 282 Co-oximeter,
Instrumentation Laboratory, Lexington, Massachusets, U.S.A.. Samples
were stored at -20°C and were analysed in duplicate, the mean of the 2
measurements being taken. Care was taken to ensure that when samples
were stored before analysis that only a minimal amount of air remained
in the tube to prevent deterioration of the sample. On testing this there
was no change in measurements on samples tested daily on up to 5
consecutive days.
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2.4. 99mTc.DTPA LUNG CLEARANCE.
2.4.1. 99mTc_DTp.A administration and data collection.
Except for an initial sham study each subject inhaled 1200 megabequerels
(MBq) of nebulised 99nvpc_DTPA from an Ultravent nebuliser
(Mallinkrodt Medical Ltd., Petten, Holland) at a radioactive concentration
of 1.8 graybequerels (GBq)/2ml (Figure 2.1). The MMAD (+SD) of the
particles generated is 0.59±0.04^m with a GSD of 1.79+0.14jum as
measured by a seven stage cascade impactor (Smith et al., 1992). A flow of
12 litres per minute O2 was used to generate the aerosol, which subjects
inhaled for 2 minutes, while supine and wearing a noseclip, during
normal tidal breathing to prevent proximal deposition through turbulent
air flow (Brain and Valberg, 1979). RR was counted during the 2 minute
inhalation period. Subjects were then imaged supine using a Siemens
gamma camera positioned posteriorly with a 140 kilo electron volt (keV)
low energy, all purpose collimator (Siemens pic., Bracknell, England)
linked to a Bartec computer (Bartec Medical Systems Ltd., Farnborough,
England) and Unix Sun workstation (Sun Microsystems Inc., Camberley,
England) with Micas System V software (Nodecrest Ltd., Byfleet,
England). Counts were acquired in 30 second time frames for 30 minutes
at a resolution of 128x128. An intravenous injection of 20MBq 99mjc_
DTPA at a concentration of 50MBq/2.5ml was given at 20 minutes to
correct for background activity.
2.4.2. Image analysis.
A typical lung ventilation image is shown in Figure 2.2. A region of
interest was drawn with a cursor around each lung field (Figure 2.3) at
peak activity, approximately 2 pixels within the outermost lung contour
avoiding the mediastinum. No activity was seen to accumulate in the
region of the thyroid gland. In initial studies both corrected and
uncorrected analyses were performed. A background region of interest
(ROI) was drawn over the inter-renal area (Langford et al., 1986) and over
each shoulder excluding lung tissue (O'Doherty et al., 1985b), following
the intravenous correction (Figure 2.3). Each ROI was normalised for area
and a correction made for 99mpc decay. A semi logarithmic plot of time
versus activity was then made for all ROI's (Figure 2.4). Uncorrected
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Figure 2.2. Typical lung ventilation image
42
Figure 2.3. Lung and background regions of interest
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Figure 2.4. Semi logarithmic plot of time versus activity for all regions of
interest. RL-right lung, LL-left lung, IR-inter-renal, RS-right shoulder, LS-











analysis was made on the first 7 minutes after peak activity. This method
is used by certain groups as it is assumed that no significant background
accumulation of isotope occurs within this period (Rinderknecht et al.,
1980, Mason et al., 1983). Other groups believe that a correction factor for
recirculating background activity is required (Jones et al., 1980, Minty et
al., 1981, O'Doherty et al., 1985b, Langford et al., 1986). This was calculated
from the ratio of the increase in counts over each lung field and the
increase over the appropriate background ROI's following the
intravenous injection. Each point in the background curves was
multiplied by the appropriate ratio. The corrected background curves
were then subtracted from the uncorrected lung curves.
Monoexponential lung clearance was observed and the time for lung
activity to fall to 50% of the initial value (t50) was calculated by linear
regression analysis of the first 20 minutes of the corrected lung curves.
2.5. BRONCHOSCOPY AND BRONCHOALVEOLAR LAVAGE.
2.5.1. Sedation and preparation.
Patients were sedated with intravenous cyclimorph (5-10mg)
immediately prior to the procedure and intravenous atropine (0.6mg)
was given. Topical lignocaine was applied to the nasopharynx (4% 0.5mls
and 2% 2mls) and to the vocal cords and major airways (2% 6mls).
2.5.2. Bronchoalveolar lavage kit.
The BAL kit is shown in Figure 2.5. The spiggots, Y-connectors, bottles
and caps were obtained from A. and J. Beveridge, Edinburgh, Scotland
and re-used after sterilisation. The catheters (14 suction catheters, 50cm)
were supplied by Mediplast, Taby, Sweden, the A60 extension set
(1250mm wide bore) by Avon Medicals, Hythe, England and the 2 way tap
(865.00) by Vygon, Cirencester, England.
2.5.3. Technique. (Figure 2.6).
The bronchoscope was wedged into a segment of the middle lobe or
lingula (or in 1 case the left lower lobe). Two hundred and forty mis of
warmed normal saline in 30ml aliquots was introduced and aspirated
immediately. Subjects were given oxygen (2-3 litres per min) throughout
the procedure.
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Figure 2.6. Bronchoalveolar lavage
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2.5.4. Processing.
The bronchoalveolar lavage fluid (BALF) was immediately filtered
through a sterile funnel (A. and J. Beveridge, Edinburgh, Scotland)
through 4 sterile gauze swabs and then centrifuged at 250g for 10 minutes
at 4°C to remove most of the cells. The supernatant was centrifuged again
at lOOOg for 10 minutes at 4°C to produce completely cell free fluid. The
cell pellet was rinsed in phosphate buffered saline (PBS) and counted
using a haemocytometer. Viability was ascertained by exclusion of Trypan
blue. Cell differentials were performed on cytospin preparations
(Shandon, Pittsburgh, PA, USA) stained with Diff Quik.
2.6. BIOCHEMICAL ASSAYS.
2.6.1. Albumin.
Serum albumin was assayed by a standard technique. Albumin in BALF
was measured by an immunoturbidometric method (Boehringer
Mannheim, Lewes, England). Concentrations of BALF constituents were
calculated in ELF using the albumin method assuming its level in ELF to
be 10% of the plasma albumin level (Ward et al., 1993).
2.6.2. Superoxide anion.
Generation of O2 ~ by mixed BAL leucocytes (2.5x10s cells) was measured
by SOD (37.5^gml"l) inhibitable reduction of ferricytochrome c (Johnston
et al., 1975). After 120 minutes incubation at 37°C in 95% air and 5% CO2
the samples were spun at 1400g for 5 minutes at 4°C and release of 02-~,
either spontaneously or when stimulated with phorbol myristate acetate
(PMA) ljugml~l was measured. The difference in absorbance of the
supernatant fluid, in the presence or absence of SOD, was determined
using a Pye Unicam 8700 series UV/VIS spectrophotometer at 550nm.
The amount of reduced cytochrome c was calculated based on an
extinction coefficient of 21.0mM~lcm~l for cytochrome c. Measurements
without SOD were performed in triplicate and those with SOD single
estimates.
2.6.3. Products of lipid peroxidation.
The level of plasma or BALF products of lipid peroxidation was
measured as TBARS (Yagi, 1976). This is the most popular method for
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measuring the extent of lipid peroxidation, although the fluorescent assay
used is not as sensitive as HPLC (Petruska et al., 1990), which was
however not available to us. We have recently demonstrated increased
lipid peroxidation in the plasma of healthy chronic smokers with the
fluorescent assay (Rahman et al., 1996). Blood was spun at 3000 rpm for 10
minutes at room temperature. EDTA at a final concentration of ImM was
added to BALF. Plasma lOOgl or BALF 500/d in duplicate were mixed
with 10% perchloric acid (v/v), pH 2.5. The resulting supernatant was
reacted with 0.67% TBA (w/v) at 95°C for 15 minutes. After cooling the
coloured complex was extracted with n-butanol and read at 532nm against
a blank containing no plasma; O.lnmole to lnmole of 1, 1, 3, 3-
tetramethoxypropane was used as an internal standard. The final result
was expressed as jUmoles of MDA formed per litre of plasma or BALF.
2.6.4. Trolox equivalent anti-oxidant capacity.
The anti-oxidant capacity of plasma and BALF was measured as TEAC
(Figure 2.7) calculated by defining the concentration in mmol/1 of Trolox
(6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-carbansaeure), a vitamin E
analogue, having the equivalent anti-oxidant capacity to a 1mmol/1
sample of the plasma or BALF under investigation (Miller et al., 1993).
The working solution of Trolox used was 2.5nmoles in lOjul PBS at pH
7.4. Metmyoglobin was prepared and purified after mixing stock
myoglobin type III (400gM) in 5mmol/l PBS at pH 7.4 with an equal
volume of freshly prepared potassium ferricyanide (740^M). The mixed
solution was dialysed at 4°C in dialysis tubing against 200 times its
volume (400mls) of PBS with change of buffer 3 times, twice after 2 hours
and finally after 15 minutes and the absorbance (A) checked at 490, 560,
580 and 700nm on a Pye Unicam 8700 spectrophotometer.
Whitburn's equation was applied to calculate the final purified
metmyoglobin (MetMb) concentration (Whitburn et al., 1982):
(Met Mb) = 146 A490 - 108 A56O + 2.1 A58O
The background was corrected by subtracting the reading at 700nm. The
final concentration was diluted down to approximately 70piM.
Myoglobin, Fe (IV)





ABTS Myoglobin, Fe (III)
Figure 2.7 Measurement of Trolox equivalent anti-oxidant capacity
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Ten mis of venous blood was withdrawn into a lithium-heparin tube,
centrifuged and the plasma removed and stored at -20°C prior to analysis.
BALF was processed as in 2.5.4. without further modification. The
reaction mixture (1ml total) contained metmyoglobin 70jumol 1"! (36/d),
ABTS 500/iM (300f/l) and an appropriate volume of PBS mixed with
Trolox (0-50jtd) or plasma (10;d) or BALF (250-500jul). The reaction was
initiated by the addition of freshly prepared IT2O2 450jumol 1"! (167^1).
This gave final concentrations of 2.5^mol 1"! MetMb, 150/imol 1~1 ABTS
and 75jumol 1"! Pf202- The mixture was inverted and incubated at room
temperature for 12 minutes. The production of the coloured radical
ABTS+- was measured on the spectrophotometer at 734nm. All
measurements were performed in quadruplicate. The stability of the
measurement was studied in plasma as shown in Table 2.1.
2.6.5. Glutathione.
Reduced and oxidised (GSSG) glutathione in BALF and mixed BAL
leucocytes was estimated according to the method of Tietze (Tietze, 1969)
(Figure 2.8) using a Unicam Pye 8700 scanning spectrophotometer at
412nm. A total of 2xl06 cells were used in each assay. After spinning at
lOOrpm at 4°C for 5 minutes the supernatant was discarded. Two mis of
freshly prepared cold 0.6% sulphosalicylic acid (SSA) was added to the
pellet, sonicated on ice and vortexed thoroughly. The sample was then
centrifuged at 2500rpm at 4°C for 10 minutes and split equally for analysis
of GSH and GSSG. For analysis in BALF a 2ml sample was also split
equally and both cell supernatant and BAL treated as follows. The GSH
sample was kept on ice until use. Twenty ^1 of 2-vinyl pyridine (2-VP)
was added to the GSSG sample, vortexed and kept at room temperature
for 1 hour. Sixty jul of triethanolamine solution diluted 1:2 with distilled
water was added and the sample then kept on ice. Assay tubes were set
upas follows, reagents being added in this order; 700fd buffer (600jul if
adding 100/d sample), lOOfd dithionitrobenzoic acid (DTNB) (freshly
prepared in buffer and sonicated in a water bath for 5-10 minutes if
necessary), lOOjul GR (in buffer), lOOjul (f-NADPH (in buffer). If sample
rather than blank was being measured lOOjul was added at this stage. The
assay tubes were then mixed and read at 412nm for 2 minutes and the
increase in absorbance recorded. Standards for GSH and GSSG were
prepared in buffer, 5 to 50jul volumes added to the assay tubes and again
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Table 2.1. Stability of the measurement of Trolox equivalent anti-oxidant







































































































































































































































GSSH + NADPH + H+ ► 2GSH + NADH+
412nm
2GSH + DTNB ► GSSG + 2TNB
Figure 2.8 Measurement of glutathione
the buffer volume altered appropriately. Buffer was prepared by adding
16mls 0.1M potassium di-hydrogen phosphate (KH2PO4) to 84mls 0.1M
di-potassium hydrogen phosphate (K2HPO4) both diluted in distilled
water made up to 200ml. Finally 5mM EDTA-Na2 was added to give 0.1M
K-P 5mM EDTA buffer pH 7.5. All measurements were performed in
duplicate.
2.7. OZONE EXPOSURE.
2.7.1. Ozone exposure in vivo.
Compressed air was purified and filtered through Purafil (Purafil
Corporation, Sutton Coldfield, England) and activated carbon filters
(Spirax Monnier 1X1, Spirax Sarco, Cheltenham, England), which
removed NOx and hydrocarbons and then through a HEPA filter (Spirax
Monnier IC3A). It was warmed and humidified and passed along Teflon
tubing at 140 litres per minute to a perspex face mask and shield worn by
the subject (Figure 2.9). All fittings in contact with ozone were made of
either stainless steel or Teflon. Ozone was produced by passing medical
grade oxygen through an electric arc ozonator Type BA. 023 (Wallace and
Tiernan, Tonbridge, Kent, England) and was injected into the air stream
at a sufficient distance from the subject to ensure good mixing of the
ozone. A sample of the air ozone mixture was drawn from the mask and
monitored continuously by an ozone analyser (Series 49-100/103,
Thermoelectron Corporation, Warrington, England) . with reference to a
primary ozone source (Institute of Terrestrial Ecology, Edinburgh
University, Scotland).
2.7.2. Ozone exposure in vitro.
A549 cells were exposed to ozone in a specially constructed exposure
chamber (Figure 2.10) in a negative pressure cabinet (Figure 2.11). Again
all fittings in contact with ozone were made of either stainless steel or
Teflon. Medical grade air was further filtered and purified as above and
passed to both the ozone and control exposure chambers at 2 litres per
minute. Ozone was produced by passing medical grade oxygen through a
UV ozone analyser and generator (Series 49-100/103, Thermoelectron
Corporation, Warrington) and injected into the air stream passing to the




Figure 2.10. In vitro ozone exposure chamber
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Figure 2.11. Negative pressure cabinets
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allowed to equilibrate for 20 minutes according to the formula t99=K x
V/F where V is the volume of the chamber (8.2 litres), F is the total flow
through the chamber (2 lmin~l), t99 is the time required to attain 99% of
the equilibrium concentration and K is a constant which for 99% is 4.605.
It was continuously monitored by the above analyser. The chambers were
humidified and the temperature maintained at 37°C.
2.8. IN VITRO STUDIES.
2.8.1. Cell culture.
The alveolar type II epithelial cell line, A549, was maintained in
continuous culture in 75ml flasks at 37°C, 5% CO2 in Eagle's minimal
essential medium (MEM) which contained 10% foetal bovine serum
(FBS), 72jugml~l benzylpenicillin, 50^gml~l streptomycin, L-glutamine
20mM and sodium bicarbonate (NaHC03"). When required, confluent
monolayers of A549 cells were washed twice with Dulbecco's PBS.
Thereafter, trypsin-EDTA solution was added to detach the cells. The cells
were then washed with MEM containing 10% FBS at 200g for 10 minutes
to neutralize the trypsin and resuspended in MEM with 10% FBS.
2.8.2. Epithelial permeability (Figure 2.12).
A549 cells were grown to confluence in 10mm Nunc tissue culture
treated inserts in MEM plus 10% FBS. This was replaced for the exposure
and permeability assay by MEM plus 2% bovine serum albumin (BSA).
The luminal medium was removed during the exposure to allow ozone
to interact with the cell monolayer as the inserts were not large enough to
allow medium to rock back and forth over the monolayer. After exposure
the luminal medium was replaced and a 5gl aliquot of 125I-BSA was
added to each insert for 30 minutes. Two standard 5jul reference aliquots
of 125I-BSA and the proportion having passed through the monolayer to
the well were counted in a gamma well counter (LKB, Wallac, Finland)
before and after precipitation with 20% trichloroacetic acid (TCA).
Epithelial permeability was then expressed as a percentage of both the
total and bound 125I activity in the well with reference to the standard
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Figure 2.12. In vitro epithelial permeability assay
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2.8.3. Measurement of glutathione.
A549 cells (3xl06) were seeded onto 30mm plastic petri dishes at a
concentration of lxl06mH and grown overnight in MEM plus 10% FBS.
Ozone exposure was performed in 0.9mls serum free medium. This
allowed 50% of the cells to be exposed to ozone for 30 seconds in each
minute due to rotation of the tilted platform. Following exposure the
medium was removed and the cells washed twice with PBS and the cells
removed by incubation with trypsin-EDTA 10% for 2 minutes at 37°C.
Cell numbers were counted using a haemocytometer and viability
estimated by Trypan blue exclusion. Total and reduced glutathione were
measured as above in the medium and the cells by the method of Tietze
(Tietze, 1969). Studies were performed in triplicate.
2.8.4. Measurement of protein mixed disulphides.
Cells were prepared as for the measurement of GSH and the cell pellet
retained for the measurement of protein mixed disulphides (PrSSG). To
quantify GSH released from PrSSG, the cell pellet obtained after 0.6% SSA
was homogenised and treated with sodium borohydride (NaBH4) to
release GSH from the PrSSGs then neutralized with phosphoric acid and
spun at 15 OOOg for 15 minutes (Burchill et al, 1978). GSH released from
PrSSG was determined by the Tietze method involving DTNB-GSSG
reductase as described above (Tietze, 1969) with slight modifications
(Roberts and Francetic, 1989). The increase in the absorbance at 412nm
was recorded for 2 minutes at 25°C on a Pye Unicam 8700 series UV/VIS
spectrophotometer. The results were expressed as the amount of GSH, in
nmoles, released from PrSSG per mg of protein.
2.8.5. Cytoskeletal assessment.
A549 cells (4xl06) were seeded onto Nunc single chamber glass slides at a
concentration of lxl06ml~l and grown overnight in MEM plus 10% FBS.
Ozone exposure was performed in 0.9mls serum free medium. Following
exposure the medium was removed and the cells washed twice with PBS
and then fixed in 0.75ml O.lmgmH lysophosphatidylcholine in 3.7% v/v
formaldehyde for 15 minutes at 37°C. The cells were washed twice further
in PBS and then incubated in PBS containing 20% normal rabbit serum
for 10 minutes at room temperature. The serum was then drained and
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the cells incubated with 0.15juM rhodamine-conjugated phalloidin
containing 0.2% BSA and 0.1% sodium azide for 20 minutes at room
temperature. Following 2 further washes with PBS the cells were
mounted in 50% glycerol in PBS and sealed with clear nail varnish. The
slides were divided along their length into 4 equal areas and 100 cells
were assessed in each of the 2 end areas. Each cell was considered to have
either normal or disrupted cytoskeleton on light microscopy (LM). The
number of cells with normal cytoskeleton was then expressed as a
percentage. Slides were viewed with an Olympus BH-2 RFCA fluorescent
microscope (Olympus Optical Co. (U.K.) Ltd., London, U.K.) and
photographed with an Olympus OM-4Ti camera using Kodak
Ektachrome 64Ti colour film.
2.9. STATISTICS.
All data are presented as mean+SE.
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CHAPTER 3. A COMPARISON OF 3 METHODS OF MEASURING
99mTc_DTPA CLEARANCE FROM LUNG TO BLOOD AS AN INDEX OF
AIRSPACE EPITHELIAL PERMEABILITY AND THEIR REPEATABILITY.
3.1. INTRODUCTION.
One of the earliest demonstrations of the permeability of the respiratory
epithelium was in 1857 when curare was seen to produce paralysis and
death when introduced into the respiratory tract of a dog (Bernard, 1857).
In recent years it has been extensively studied by measuring the lung
clearance of inhaled ^mpc.pyppA. This technique was first used as a
means of assessing regional ventilation as a replacement for the
radioactive gas D3xenon (Taplin and Chopra, 1978). The inhaled 99mpc_
DTPA particles were noted to pass from the lungs to the blood at a rate of
about 1% per minute. It was expected that diseases which thickened the
alveolar-capillary membrane such as interstitial lung disease (ILD) would
exhibit a reduced rate of clearance. However the converse was found to be
true (Rinderknecht et al., 1980). Increased rates of ^^mTc-DTPA lung
clearance occur in numerous conditions, including ARDS (Barrowcliffe
and Jones, 1989), Pneumocystis carinii pneumonia (PCP) (Robinson et al.,
1991), after cytotoxic agents (O'Doherty et al., 1986) and amiodarone (Terra
Filho, 1989), ozone exposure (Kehrl et al., 1987) and acute asthma
(Lemarchand et al., 1992). Cigarette smoking produces a rapidly reversible
increase in 99mpc_p)ppA clearance (Jones et al., 1980, Minty et al., 1981,
Mason et al., 1983, Kennedy et al., 1984). Peripheral deposition is
associated with faster clearance (Oberdorster et al., 1986) as is positive end
expiratory pressure (Nolop et al., 1987) and raised lung volume (Nolop et
al., 1986).
Despite extensive use of this technique in studies of alveolar-capillary
membrane integrity, a comparison of the different methods, as they are
employed in practice, has not been performed. A wide range of normal
t50 values for ^^mTc-DTPA clearance has been quoted in the literature
[44.4-117.5 minutes] (Table 3.1). This is likely to reflect the sensitivity of
99mpc_]3XPA clearance to changes in lung volume (Rizk et al., 1984,
Nolop et al., 1986, Nolop et al., 1987). However the method of correcting
for background activity may also contribute (Rinderknecht et al., 1980,
O'Doherty et al., 1985b, Langford et al., 1986). Two groups have compared
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uncorrected and corrected analyses on complete clearance curves
(O'Doherty et al., 1985b, Langford et al., 1986). However uncorrected
analysis is normally restricted to the first 7-10 minutes of the clearance
curve (Rinderknecht et al., 1980, Mason et al., 1983). I studied 8 non-
smokers and 7 smokers, each on 2 occasions, with the aim of comparing 3
methods of analysis, including their repeatability, as they are employed in
practice.
3.2.METHODS.
3.2.1. Subjects (Table 3.2).
The non-smokers (M:F 8:0) had normal ventilatory capacity which was
significantly higher than the smokers (M:F 4:3), who had mild airflow
limitation. The non-smokers were also significantly younger. There was
no significant difference in subject characteristics between visits 1 and 2 in
either the non-smokers or smokers. All were free of respiratory infection
and had no significant medical problems.
3.2.2. Study design.
Subjects attended for an initial sham study, performed without isotope,
in order to accustomise them to the test and eliminate as much as
possible any variations in TV, inspiratory flow and functional residual
capacity. They were then studied on 2 occasions (visits 1 and 2) over
variable time intervals (1-30 weeks) with initial and return studies
overlapping to help negate any possible influence of change in the test set
up with time.
On each of the 3 occasions smokers were asked to refrain from smoking
for 12 hours. Spirometry and COHb measurements were performed on all
visits prior to study.
3.2.3. Stability of 99mTc.DTPA>
In 1 non-smoker and 4 smokers thin layer chromatography of the
residual 99mpc_[yx'py\ jn the nebuliser and urine demonstrated 0% and
<0.2% dissociation respectively into DTPA and free pertechnetate
(Zimmer and Pavel, 1977).
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Reference Non-smokers Smokers Method
Jones et al., 1980 59+5 20+2 C
Mason et al., 1983 81+10 15+1 U
Kennedy et al., 1984 110+22 42+5 c
O'Doherty et al., 1985 83+6 30+3 u
70+6 20+3 c
Langford et al., 1986 66 33 u
60 27 c
58 26 c
Nolop et al., 1986 55+7 22+4 c
Nolop et al., 1987 52+6 28+5 c
Thunberg et al., 1989 91+5 28 (range 22-46) c
Table 3.1. Values for 99mTc_pyppA clearance (t50, minutes, mean±SE)
from lung to blood in non-smokers and smokers, in previous studies,
uncorrected (U) or corrected (C) for recirculating background activity.
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Non-smokers (n=8) Smokers (n=7)
Visit 1 Visit 2 Visit 1 Visit 2 NS v S
Age (years) 32+2 46+4 p<0.01
FEVl (litres) 4.5+0.2 4.5+0.2 3.1+0.5 3.1+0.5 p<0.001
%Predicted 102.8+3.3 102.5+3.4 88.9+8.9 89.1+7.9 p<0.05
FVC (litres) 5.4+0.2 5.5+0.2 4.3+0.5 4.2+0.6 p<0.01
COHb (%) 0.9+0.1 1.1+0.1 2.5+0.5 2.8+0.4 p<0.001
RR (per min) 10+1 9+1 12+1 12+1 p<0.01
Table 3.2. Subject characteristics (mean+SE) in the non-smokers (NS) and
smokers (S) studied. RR-Respiratory rate.
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3.2.4. Ethical approval.
The study was approved by the local medical ethics committee and all
subjects gave written informed consent.
3.2.5. Statistical analysis.
The subject characteristics in the non-smokers and smokers were
compared between the 2 groups by the unpaired t-test and within the
groups, between visits 1 and 2, by the paired t-test.
For comparison the 3 methods of analysis were combined, the data
transformed to natural logarithms, and a hierarchical analysis of variance
(ANOVA) performed. The mean values between visits 1 and 2 were
compared for each technique by paired t-test. Correlation between the
uncorrected t50 values and the correction factors for the 2 corrected
methods of analysis was performed by a 2 variable parametric analysis.
Repeatability of the 3 methods of analysis was defined according to the
single determination standard deviation and the 95% range of the
repeated measurements (Chinn, 1991). For all 3 methods the difference
between the values for ^^mTc-DTPA clearance at visits 1 and 2 was
related to the mean of these values. The data were therefore log
transformed and the standard deviation of the differences between log
values for visits 1 and 2 was calculated for each method and divided by V2
to give the single determination standard deviation. The 95% range,
expressed as + k, is derived from this as + 2 x the single determination
standard deviation. This may then be antilogged to x/-s- antilog(k) to
indicate the limits around a single measurement, on a numerical scale,
that must be regarded as possible values for the true measurement
(Chinn, 1991). The values expressed in the tables are numerical. A level
of <0.05 was considered statistically significant. Statistical advice was
given and the hierarchical ANOVA performed by Dr. W Adams,
Department of Medical Statistics, Edinburgh University, Edinburgh. All
other calculations were performed on Statistica/Mac™, Release 1.7,
Copyright StatSoft, Inc. 1991-1992.
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3.3. RESULTS.
Individual t50 values are shown in Figure 3.1. Values for right and left
lungs are shown. Absolute and percentage differences from visits 1 to 2
are given in Table 3.3. The uncorrected values in non-smokers were
higher on visit 2 in 4 subjects, lower in 4 subjects and in 2 subjects
showed no consistent change. There were no consistent differences
between the 2 visits with the 2 background corrected methods in non-
smokers nor with any of the 3 methods in smokers.
Mean t50, regression coefficients and their standard error values and
correction factors (inter-renal and shoulder corrected methods) for the
time-activity curves are shown in Table 3.4. All the clearance curves were
monoexponential. The regression coefficients for the curves are given to
show the tightness of fit to a monoexponential line. They are however
rather insensitive to different qualities of fit around curves with similar
slopes and are more sensitive to increases in slope. Thus the r values for
the smokers are better than those for the non-smokers whose clearance
curves have such a small slope. The standard error values for the curve
fitting are thus also given in this study, the combination providing a
better indication of the variation in the data from which the time-activity
curves were calculated.
Mean t50 values in non-smokers were significantly higher than in
smokers with each of the 3 methods of analysis (p<0.001). In non-smokers
the uncorrected method gave higher mean t50 values than the inter-
renal (p<0.001) and shoulder (p<0.001) methods of correction. The inter-
renal method gave lower values than the shoulder corrected method
(p<0.05). In smokers there was no difference in the values obtained
between the 3 methods of analysis. There was no correlation between the
uncorrected t50 values and the correction factors for the background
corrected methods of analysis overall, or in non-smokers and smokers
separately.
There were no significant differences between the mean values obtained
at visits 1 and 2 in either non-smokers or smokers for any of the 3
methods of analysis. The repeatability of the 3 methods of analysis is
given in Table 3.5. There was no significant difference between the
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Figure 3.1. 99irrrc_DTpi\ lung clearance (t50, mean+SE) values at visit 1


































































































































































































































































































































Table 3.4.99mTc_E>TT>A clearance from lung to blood in non-smokers and
smokers showing time (minutes) to 50% clearance (t50), regression
coefficients (r) and their standard errors (minutes, SEr) for slope and
tightness of monoexponential fit to the time-activity curves and the















































































































































































































































Table 3.5. Single determination standard deviation (s) and 95% range for
repeated measurements of 99nvrc-DTPA clearance, from lung to blood,
on 2 occasions, according to the three methods of analysis. The values
have been transformed from natural logarithms. All-non-smokers (NS)
plus smokers, U-uncorrected analysis, IR-inter-renal correction, S-
shoulder correction.
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methods in all subjects or in non-smokers and smokers analysed
separately.
3.4.DISCUSSION.
I have compared 3 methods of analysing the clearance of 99nvrc_pyxTA
from the lungs to blood, as they are employed in practice. Table 3.1 shows
that the values obtained in previous studies have varied greatly.
Although the mechanism of 99mpc_p)ypA transport across the alveolar
capillary membrane is not known the most important factor affecting
99mTc-DTPA clearance is thought to be its sensitivity to change in lung
volume. It may be increased within 1 to 2 minutes of an increase in lung
volume (Rizk et al., 1984, Nolop et al., 1986, Nolop et al., 1987). This may
be due to an increase in surface area available for clearance of 99mpc_
DTPA, greater access to thinner alveolar capillary membrane, change in
lung surface characteristics, increase in epithelial permeability, widening
of intercellular junctions, recruitment of more permeable lung units,
change in the surfactant layer or increased negative pulmonary
interstitial pressure (Barrowcliffe et al., 1987, Smith et al., 1992). However
the method of allowing for background activity may also contribute to the
wide range of normal values (Rinderknecht et al., 1980, ODoherty et al.,
1985b, Langford et al., 1986). This study examines the effect of the method
of analysis employed on the absolute values and repeatability of 99mpc_
DTPA clearance, in particular the incorporation of a correction for
recirculating background activity.
Lung clearance of 99mpc_p>ppA [s affected by many other factors.
Bronchial absorption of 99mpc_p)ppA is slower than alveolar absorption
when mucociliary clearance is taken into account (Barrowcliffe et al.,
1987). This may be due in part to binding of 99mpc_p)ppA t0 mucus
(Barrowcliffe and Jones, 1987). Aerosols with MMAD less than 2jUm will
be predominantly deposited peripherally (Barrowcliffe and Jones, 1987).
In some studies in humans clearance has been found to be significantly
faster from apical compared to basal regions. This has been attributed to
larger alveolar surface area and thus increased permeability in the apices
(Rinderknecht et al., 1980). An anterior-posterior difference has been
found in the supine position with more rapid clearance posteriorly. This
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is thought to be due to the increased perfusion in the dependent dorsal
regions (Thunberg et al., 1989). 99nrpc-DTPA clearance is also affected by
removal from blood (Rizk et al., 1984). It is increased by exercise perhaps
due to recruitment of capillaries (Meignan et al., 1986).
One must ask whether a background correction is required. The initial
studies in the U.K. incorporated a correction for recirculating background
activity with the use of a second scintillation probe placed over the thigh,
the first collecting activity over the lung (Jones et al., 1980, Minty et al.,
1981). An intravenous injection was given to assess the contribution of
soft tissue and blood activity. This form of correction assumes that
activity collected over a non-thoracic area reflects the situation in the soft
tissues and vessels of the thorax and that 99mpc_p)ppA given
intravenously in this way is distributed in the same fashion as that
absorbed through the airspace epithelium. Time is required following the
bolus for equilibration with the soft tissues. Background correction, by
monitoring accumulation in the thigh, has been validated by Barrowcliffe
and co-workers in pigs. The left lung was selectively intubated to receive
99mTc-DTPA. and an intravenous bolus was given after 30 minutes. No
difference was found in the corrected t50 from the left lung derived from
background activity in either the right lung or thigh (Barrowcliffe et al.,
1988). Studies performed in North America have not used a correction
since analysis has been confined to the first 7-10 minutes of the clearance
curve (Rinderknecht et al., 1980, Mason et al., 1983). This makes the
assumption that insufficient background activity accumulates over this
short period to constitute a problem. In smokers however considerable
background activity can be seen already accumulating over the first 7-10
minutes of analysis although this may only become significant where the
t50 is less than 10 minutes. O'Doherty and co-workers used an
intravenous correction employing a gamma camera technique and
background regions over both shoulder areas. It appears from their data
that about 30% of the total lung activity constitutes background at 30
minutes in smokers. They found that the correction factor increased with
the permeability of the alveolar capillary membrane although I found no
such relationship (O'Doherty et al., 1985b). Langford and colleagues
modified this technique with a background region between the kidneys
(Langford et al., 1986). They claimed to have found a technique that did
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not require an intravenous bolus as the increase in activity in the
background region was the same as that over the lungs giving a
correction ratio of 1. This has however not been our experience with this
method and I believe that an intravenous correction is required with it.
In our study there was no difference between the 3 methods of analysis in
the t50 values obtained in smokers. Previous studies comparing
uncorrected and corrected analyses have shown the corrected t50 values
to be significantly less in both smokers and non-smokers. However these
studies did not compare the methods as they are used in practice.
Uncorrected analyses were performed on the complete clearance curves
rather than the first 7-10 minutes only (O'Doherty et al., 1985b, Langford
et al., 1986). It is likely that uncorrected and corrected t50 values for such
curves will differ thus demonstrating the validity of background
correction. In my view it is desirable to use a background correction in
studies where clearance may be rapid, particularly when it may be
biexponential, to avoid the confounding effect of rapidly accumulating
background activity. In smokers considerable background activity can be
seen accumulating over the first 7-10 minutes, thus the claim that there is
little recirculating background activity during uncorrected analysis of this
period seems unlikely in curves having a t50 of less than 10 minutes, of
which in this study there was only 1. Background correction allows a
longer duration of data acquisition without including recirculating
background activity (Barrowcliffe et al., 1987). There is no way of knowing
in advance how rapid ^m-pc.pyppA clearance will be or if a curve is going
to be biexponential, although studies in smokers have consistently
yielded monoexponential clearance curves. Background correction
enables the analysis of any degree of change in the 99mpc_Qppi(\ clearance
curve from normal non-smoker to the effects of a range of heterogeneous
pathologies which produce biexponential curves, that is, the corrected
curve can be used to study the evolution of 99mpc_p)ppy\ clearance in an
individual with a progressive then resolving lung injury.
Non-smokers have less background activity than smokers and thus
differences between the uncorrected and corrected t50 values in this study
are likely to be due to technical factors. In non-smokers the clearance
curves have such a small slope that the peak activity following
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inhalation was less sharply differentiated than in the smokers and was
thus more difficult to identify. This may explain the higher values
obtained by the uncorrected analysis of the first 7 minutes of the curve in
non-smokers compared to the corrected values obtained from the first 20
minutes. The lower t50 values obtained from the inter-renal compared to
the shoulder method of correction in non-smokers was probably due to
the greater vascularity of the inter-renal background.
Previous studies of intra-individual coefficients of variation (CV's) are
given in Table 3.6. Rizk and co-workers studied 5 anaesthetised, paralysed
and ventilated dogs using an uncorrected method of 99nvpc-DTPA lung
clearance. They found a mean t50 of 24.6+5.3 (+SD) minutes which was
not significantly different when repeated at least 72 hours later (26.7+7.9
minutes). There was substantial intra-individual variation but a CV is
not quoted (Rizk et al., 1984). O'Doherty and colleagues studied 7 non-
smokers and 6 smokers on 2 occasions and found that the correction
factors were not significantly different between visits (O'Doherty et al.,
1985b).
Smith and co-workers found that the least variability between and within
subjects with an uncorrected method was given by monoexponential
analysis after inhalation of 99mpc_p)ppA by tidal breathing, followed by
scanning for 30 minutes, compared to VC inhalation of isotope, shorter
scanning times and biexponential analysis. They found that several VC
manouevres prior to measuring 99mpc_p>ppi\ clearance resulted in faster
clearance rates for 10 to 20 minutes. This was associated with a more rapid
curvilinear clearance suggesting a transient difference in pulmonary
permeability, surface area or volume of ELF. They recommended that
subjects rest for 20 minutes prior to inhaling the aerosol of 99mpc.p)ppA
to avoid alterations in clearance rates from deep breathing. In normal
subjects, intersubject and probably also intrasubject variability is
minimised with delivery of the aerosol supine rather than sitting (Smith
et al., 1992). This is probably because it likely reduces the difference in
regional clearance rates between upper and lower regions (Rinderknecht
et al., 1980, Mason et al., 1983). It has also been reported that keeping the
number of 99nvpc-DTPA molecules per number of aerosol particles














































































and colleagues recommended that submicronic particles with GSD less
than 1.6jum should be employed to minimise variability (Smith et al.,
1992). Measurements of total lung projections improve repeatability
(Thunberg et al., 1989)
In this study there was no difference in the mean values for ^mpc.pypPA
clearance between 2 visits in either non-smokers or smokers for any of
the 3 methods of analysis. Ozone inhalation, 0.4ppm for 2 hours, in
normal non-smokers, for example, has been shown to change the t50 for
99m'pc_p)T,pA. clearance from 117+16 (SE) to 40+10 minutes (Kehrl et al.,
1987). Repeatability in this study did not differ between the 3 methods of
analysis nor between non-smokers and smokers. It would have seemed
likely that smokers would have greater variability in epithelial
permeability over time than non-smokers due to variations in their
smoking habit but this was not seen.
In conclusion values for 99mpc_p)ppji\ clearance from lung to blood
obtained from 2 background corrected methods of analysis are the same as
those from an uncorrected analysis in a group of smokers with t50 values
greater than 10 minutes. There is no difference in the repeatability of the
technique between the 3 methods of analysis in either smokers or non-
smokers. I believe that background correction is necessary as it allows the
analysis of any form of curve, the nature of which cannot be predicted
prior to study. Background correction using an inter-renal region allows
rapid analysis. Further attempts to standardise this and other aspects of
the technique are likely to reduce the range of results in the literature.
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CHAPTER 4. EPITHELIAL PERMEABILITY, INFLAMMATION AND
OXIDANT STATUS IN THE AIRSPACES OF CHRONIC SMOKERS.
4.1. INTRODUCTION.
Cigarette smoke was first shown to disrupt the respiratory epithelium in
guinea pigs in whom penetration of the tracer horseradish peroxidase
(HRP) was observed at all levels after exposure to cigarette smoke (Simani
et al., 1974). This was reported to be maximal at 30 minutes occurring
during the exudative phase of an inflammatory reaction and returning to
normal by 12 hours in association with the repair phase (Hulbert et al.,
1981). Increased airspace epithelial permeability is found in smokers
(Jones et al., 1980) and is rapidly reversible after stopping smoking (Minty
et al., 1981, Mason et al., 1983). It occurs within 3 days of starting smoking,
is unrelated to nicotine (Minty et al., 1984) and is abolished by filtration of
the smoke to remove all the particulate material (Minty and Royston,
1985).
The total number of inflammatory cells and the number of neutrophils
in the airspaces of smokers are increased (Hunninghake and Crystal, 1983,
Martin et al., 1985, Koyama et al., 1991). They show increased oxidative
metabolic responses (Hoidal et a I., 1981) and enhanced cytotoxic potential
(Davis et al., 1988). Cigarette smoke contains lCh6 free radicals per puff
(Janoff et al., 1987). The airspaces of smokers are thus exposed to oxidants
both inhaled from cigarette smoke and released from inflammatory
leucocytes. An oxidant-antioxidant imbalance has been suggested but
never proven in the lungs of smokers and a number of lung diseases
including COPD (Rahman and MacNee, 1996).
Alterations in anti-oxidants in blood and in the lungs of cigarette
smokers have varied depending on the anti-oxidant studied. Smokers
have increased levels of the anti-oxidant GSH in their ELF (Cantin et al.,
1987). GSH and its redox enzymes are important intracellular anti¬
oxidants crucial in maintaining cell function and in protecting the
epithelium from oxidant stress.
It has been suggested that the leak in the respiratory epithelium in
smokers occurs at the corners where epithelial cells meet rather than
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along their lateral surface (Walker et al., 1982). These corners occur in
greatest concentration in the distal portion of membranous bronchioles
and in the portion of respiratory bronchioles covered by cuboidal
epithelium (Hogg 1983). Since smoking causes inflammation of terminal
and respiratory bronchioles (Niewoehner et al., 1974) and the maximum
leak occurs with the exudative phase of the inflammatory reaction it has
been proposed that the leak is associated with the repeated acute injury
caused by cigarette smoke (Hogg 1983). Increased epithelial permeability
leaves the interstitium of the lung open to other insults for example
viruses, bacteria, pollutants and allergens.
Previous human studies have not attempted to define the acute and the
chronic effects of smoking. The aim of this study was to compare the
chronic and acute effects of cigarette smoking on epithelial permeability,
inflammation and oxidant status in the airspaces of chronic smokers.
4.2.METHODS.
4.2.1. Patients.
Fourteen regular cigarette smokers underwent 99mpc_p)TPA lung scans
after abstaining from cigarette smoking for 12 hours (chronic smoking)
and 1 hour after smoking 2 cigarettes (G2, Imperial Tobacco) (Figure 4.1)
to a standard protocol (acute smoking). The characteristics of these
subjects are given in Table 4.1. There was no change in spirometry
following acute cigarette smoking. The COHb was significantly higher
prior to the acute smoking than after 12 hours abstinence from cigarettes
and was further increased after smoking 2 cigarettes.
Each smoker also underwent bronchoscopy and BAL after either chronic
smoking (n=8) or acute smoking (n=7). Seven control subjects who had
never smoked were also studied with bronchoscopy and BAL. The
characteristics of these patients are given in Table 4.2. The non-smokers
were significantly younger than the acute group (p<0.05) in whom the
FEVi (p<0.05) but not %predicted was significantly lower. COHb in the
non-smokers was significantly lower than in either the acute (p<0.001) or
chronic (p<0.01) smoking groups.
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None of the subjects had a history of respiratory infection within 6 weeks
of the study.
4.2.2. Stability of 99mTc_DTPA>
In 3 chronic smokers thin layer chromatography of the residual 99mpc_
DTPA in the nebuliser and urine demonstrated 0% and <1.7%
dissociation respectively into DTPA and free pertechnetate (Zimmer and
Pavel, 1977). In 1 acute smoker these figures were 0% and 2.4%
respectively.
4.2.3 Ethics.
Ethical permission was obtained from the local medical ethics committee
and all patients gave informed written consent.
4.2.4. Statistics.
In the 99mTc_p>TpA lung clearance study all comparisons were made by
paired t-test. In the BAL study all comparisons were made by one way
ANOVA except where only 2 groups could be compared in which case
either an unpaired or paired t-test was performed as appropriate.
Superoxide anion production by mixed BAL leucocytes was analysed by
two way ANOVA. Correlation was performed by a 2 variable parametric
analysis. Statistical advice was given by Dr. TJ Peters, Senior Lecturer in
Public Health Medicine, Department of Social Medicine, University of
Bristol, Bristol. All calculations were performed on Statistica/Mac™,
Release 1.7, Copyright StatSoft, Inc. 1991-1992. A level of <0.05 was
considered statistically significant.
4.3. RESULTS.
4.3.1. 99nrrc_pjpA lung clearance.
In the chronic smoking group t50 was 16.7+1.3 (mean±SE) minutes. This
was further and significantly reduced after acute smoking to 14.8+1.0
minutes (p<0.01) (Ligure 4.2). Individual values are shown in Ligure 4.3.
Mean values for 99myc_[yyp/\ clearance for right and left lungs are given
in Table 4.3. Although there was a significant difference between the right
and left lungs in both the chronic (p<0.05) and acute smoking groups

















Figure 4.2. Time for 50% clearance of ^hitc-DTPA from lungs to blood
(t50) in the chronic and acute smoking groups. Mean±SE, n=14, ** p<0.01.
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Figure 4.3. Individual values for 99mxc-DTPA lung clearance (t50) in























































































































































smoking regardless of the lung studied (right lung p<0.05, left lung
p<0.05). All correlation coefficients were 0.98 or greater for the semi
logarithmic time activity curves.
4.3.2. Bronchoscopy and bronchoalveolar lavage.
The characteristics of the BAL are given in Table 4.4. The total number of
cells recovered was 6.5 fold greater in the acute smoking group than in
the non-smokers and 11.4 fold greater in the chronic smoking group.
There was no significant difference in the volume of BALF recovered in
the 3 groups nor in the viability of the cells recovered which ranged from
72-94%.
There was a 3 fold increase in the percentage of neutrophils in BALF
obtained from the acute smoking group compared to the chronic
smoking group (p<0.05) and a 2.5 fold increase compared to the non-
smokers (ns). There was a trend towards an increase in the percentage of
eosinophils in the acute smoking group. Regarding absolute numbers
significantly increased numbers of macrophages (p<0.05) and
lymphocytes (p<0.01) were observed in BALF obtained from the chronic
smoking group compared to the non-smokers. Neutrophil numbers were
significantly increased in BALF obtained from the acute smoking group
compared to the non-smokers (p<0.05).
There was a trend towards an increased albumin concentration in BALF
(Figure 4.4) and ELF volume (Figure 4.5) in both smoking groups (Table
4.5). The values are in keeping with those given by Rennard using either
albumin or urea to correct for the concentration of other substances inELF
assuming the concentration of albumin in ELF to be one tenth that of
plasma and the concentration of urea to be equal, as it is assumed to be
freely diffusible (Rennard et al.r 1986).
Superoxide release (Table 4.6) from mixed leucocytes obtained from
chronic (p<0.01) and acute (p<0.001) smokers was significantly increased
compared to non-smokers (Figure 4.6). When unstimulated cells and
cells stimulated with PMA l^gml'l were analysed separately only a trend
towards an increase was seen in the 2 smoking groups compared to non-













































































































Figure 4.4. Bronchoalveolar lavage fluid (BALF) albumin in non-smokers





Figure 4.5. Epithelial lining fluid (ELF) volume in non-smokers and in
the chronic and acute smoking groups. Mean±SE.
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Chronic Acute Non p level
BALF albumin (/igml~l) 39.6±4.4 38.5+4.7 34.5+4.0 ns
Plasma albumin (mgml"l) 46.0+0.8 46.1+0.6 47.7+1.1 ns
BALF volume (mis) 151.2+9.0 157.9+11.8 170.0+14.5 ns
ELF volume (mis) 1.30+0.18 1.28+0.16 1.22+0.16 ns
Table 4.5. Albumin levels in bronchoalveolar lavage fluid (BALF) and
epithelial lining fluid (ELF) volume in the chronic and acute smoking



























































































































Figure 4.6. Superoxide production (mean+SE) from mixed
bronchoalveolar lavage (BAL) leucocytes, unstimulated and stimulated
with phorbol myristate acetate (PMA) lj/gml~l in non-smokers (NS) and
in the chronic (C) and acute (A) smoking groups. ** p<0.01 C v NS, ***
pcO.OOl A v NS.
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any of the 3 groups although a trend towards this was seen in the acute
smoking group.
Products of lipid peroxidation (Table 4.6) were significantly increased in
plasma in both the chronic (p<0.05) and acute (p<0.05) smoking groups
compared to the non-smokers although there was no difference between
the 2 groups (Figure 4.7). In BALF (Figure 4.8) and in ELF (Figure 4.9)
products of lipid peroxidation doubled in the chronic smokers and
increased 6 fold in the acute smokers compared to non-smokers although
these changes did not reach statistical significance.
TEAC (Table 4.7) was significantly reduced in plasma in both smoking
groups (p<0.001) (Figure 4.10). There was a trend towards a further
reduction in the acute smokers but this did not reach statistical
significance. Conversely a significant increase in TEAC was seen in BALF
(Figure 4.11) in both smoking groups (p<0.05) compared to the non-
smokers although again there was no significant difference between the 2
smoking groups. The same pattern was seen in ELF (Figure 4.12) although
the changes did not reach statistical significance.
GSH (Table 4.7) was increased 2 fold in mixed BAL leucocytes (Figure
4.13), BALF (Figure 4.14) and ELF (Figure 4.15) in chronic smokers
compared to non-smokers. This increase was abolished following acute A
weak correlation between t50 for 99nrrc_pyppA clearance in the chronic
smoking group (Table 4.8) and pack years was found (r=0.59, p<0.05) and a
trend observed for age (r=0.57, p=0.052). There was no relationship
between t50 and the number of cigarettes smoked daily or COHb. No
correlation was found between t50 for the chronic and acute smokers
together and any of the variables measured as shown in Table 4.9.
Although the percentage of neutrophils in BALF in the acute smoking
group was significantly higher than in the chronic smoking group there
















Figure 4.7. Plasma lipid peroxidation in non-smokers and in the chronic
















Figure 4.8. Bronchoalveolar lavage fluid lipid peroxidation in non-


















Figure 4.9. Epithelial lining fluid lipid peroxidation in non-smokers and
































































































































Figure 4.10. Trolox equivalent anti-oxidant capacity in plasma in non-
smokers (NS) and in the chronic and acute smoking groups. Mean±SE,






Figure 4.11. Trolox equivalent anti-oxidant capacity in bronchoalveolar
lavage fluid in non-smokers and in the chronic and acute smoking











Figure 4.12. Trolox equivalent anti-oxidant capacity in epithelial lining







Figure 4.13. Reduced (GSH) and oxidised glutathione (GSSG) in mixed
bronchoalveolar lavage leucocytes in non-smokers and in the chronic
and acute smoking groups. Mean+SE.
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1 0-1
Figure 4.14. Reduced (GSH) and oxidised glutathione (GSSG) in
bronchoalveolar lavage fluid in non-smokers and in the chronic and






Figure 4.15. Reduced (GSH) and oxidised glutathione (GSSG) in epithelial
lining fluid in non-smokers and in the chronic and acute smoking
groups. Mean±SE.
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Variable r p value n
Age 0.57 <0.052 12
Cigs daily 0.36 <0.26 12
Pack years 0.59 <0.04 12
Pre COHb -0.01 <0.96 12
Pre FEVi 0.11 <0.74 12
Pre %predicted 0.23 <0.48 12
Pre FVC 0.19 <0.56 12
Pre ratio -0.20 <0.54 12
Table 4.8. Correlations (r) between the time for 50% clearance of 99mfc-
DTPA from lungs to blood (t50) in the chronic smoking group and





















































































































































































































The respiratory epithelium is a selectively permeable barrier separating
the airways and airspaces from the submucosa and interstititium of the
lungs and the vascular components of the respiratory tract. It lines the
respiratory tract and acts as a barrier preventing the entry of potentially
noxious agents such as bacteria, viruses, pollutants and allergens.
Although cigarette smoke falls into this category, the lungs of cigarette
smokers are rendered more permeable than those of non-smokers (Jones
et al., 1980). This is a rapidly reversible (Minty et al., 1981, Mason et al.,
1983) and rapidly induced effect which is not produced by nicotine (Minty
et al., 1984) and relates neither to chronic airflow limitation (Huchon et
al., 1984), bronchial hyperreactivity (Kennedy et al., 1984, O'Byrne et al.,
1984) or small airway function (Taylor et al., 1988). Increased rates of
99nrfc-DTPA lung clearance occur in numerous conditions, including
ILD (Rinderknecht et al., 1980), ARDS (Barrowcliffe and Jones, 1989), PCP
(Robinson et al., 1991) and acute asthma (Lemarchand et al., 1992). In fact
in fibrosing alveolitis the clearance of 99mpc_p)ppA predicts the clinical
course of the disease (Wells et al., 1993) and in asbestos workers with and
without asbestosis increased ^^mTc-DTPA clearance is associated with
worse functional and radiological outcome (Al Jarad et al., 1993).
Peripheral deposition (Oberdorster et al., 1986) and deposition in the
upper lobes (Mason et al., 1983) is associated with faster clearance as is
raised lung volume (Nolop et al., 1986).
However the mechanism for increased 99mpc_p)ppA clearance is not
known. In guinea pigs exposed to cigarette smoke the tracer horseradish
peroxidase has been seen to pass through the tight junctions linking
epithelial cells at all levels and then to pass through the intercellular
pathway (Simani et al., 1974, Boucher et al., 1980) with freeze fracture
electron microscopy (EM) showing progressive disruption of tight
junctions (Boucher et al., 1980). In rabbits a significant increase in 99nvpc_
DTPA permeability following acute cigarette smoke exposure was
associated with LM and EM changes of focal alveolar oedema and
haemorrhage but no alveolar capillary membrane damage (Witten et al.,
1985). Burns and colleagues (Burns et al., 1989) showed increased
respiratory epithelial permeability to fluoroscein isothiocyanate dextran
(FITC-D) after cigarette smoke exposure in guinea pigs and alveolar
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epithelial damage. Epithelial tight junctions have a diameter of 6-10 A°
and are too small for the passage of FITC-D which has a 22 A° radius.
Transmission EM showed that the FITC-D diffused across damaged type I
pneumocytes and entered alveolar capillaries through endothelial tight
junctions which have a diameter of 40-58 A°. Increased 99m7c.p)xpj«\
clearance occurred in rats, 15 minutes after exposure to cigarette smoke,
lasting 8-9 minutes although no abnormality was found in the lung
parenchyma on LM (Mordelet-Dambrine et al., 1991). Cigarette smoke
extract inhibited intercellular communication across gap junctions in
primary hamster tracheal epithelial cells (Rutten et a I., 1988) and cigarette
smoke condensate reduced gap junction numbers by at least 60% in
primary chick embryo hepatocytes (van der Zandt et al., 1990). In cultured
rat hepatic epithelial cells and human fibroblasts the number of gap
junctions and the rate of gap junction communication was inhibited by
cigarette smoke condensate from burning but not heated cigarettes
(McKarns and Doolittle, 1991). In monolayers of porcine pulmonary
artery endothelium cigarette smoke extract caused a dose dependent
increase in the flux of 125I-BSA that was dependent on extracellular
divalent cations. The effect was reversible, independent of the surface
exposed (luminal or abluminal) and due to the vapour phase of the
extract. It occurred without evidence of cell damage but subtle
morphological changes were seen with focal retraction of individual cells
and occasional areas where gaps had formed in the monolayer associated
with focal areas of polymerised F-actin (Holden et al., 1989).
It has been proposed that epithelial permeability is associated with the
repeated acute injury caused by cigarette smoke (Hogg, 1983). I performed
paired 99mpc_[yj'pA lung clearance scans in 14 life long smokers. On 1
occasion they were asked to refrain from smoking for 12 hours in order to
eliminate the acute effects of cigarette smoke. Compliance was confirmed
by COHb measurements. On another occasion they continued to smoke
and had 2 cigarettes to a standard protocol over 10 minutes 1 hour prior
to the lung scan. Airspace epithelial permeability was still increased in
the first study, the chronic smoking study, and was increased further and
significantly by the acute smoking. This was consistent for the right and
left lungs analysed separately. The individual changes show this to be a
very consistent effect. The change from 16.7+1.3 to 14.8+1.0 minutes
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represents a change of 11% and indicates that the effect of cigarette smoke
on epithelial permeability is indeed an acute one. This is consistent with
previous reports indicating significant improvement in epithelial
permeability as rapidly as 24 hours after the last cigarette (Mason et al.,
1983). The change in epithelial permeability seen in our study was not
associated with any changes in respiratory function measured nor was
there any evidence of dissolution of the ^^mTc-DTPA compound into
DTPA and free pertechnetate to explain the increase in clearance. It was
not associated with any changes in BALF albumin concentration or ELF
volume. There was no relationship between 99mTc_p)TPA clearance and
the number of cigarettes smoked daily, the duration of smoking or the
COHb level either before or after smoking.
The total number of cells found in BALF obtained from cigarette smokers
is elevated from 2.2-4 fold (Hunninghake and Crystal, 1983, Nagai et al.,
1988, McCrea et al., 1994). The percentage of neutrophils in some studies
has been no different in smokers compared to non-smokers (Nagai et al.,
1988, McCrea et al., 1994) although in another it was 22 times greater
(Hunninghake and Crystal, 1983). However the absolute number of
neutrophils is consistently raised being 87, 1.6 and 2.6 fold elevated in
these 3 studies (Hunninghake and Crystal, 1983, Nagai et al., 1988, McCrea
et al., 1994). Long-term cigarette smoking also increases the number of
neutrophils in the peripheral circulation and in lung parenchyma
(Niewoehner et al., 1988, McGowan and Hunninghake, 1989). Acute
cigarette smoking has been shown to attract circulating neutrophils to the
pulmonary vasculature (MacNee et al., 1989), mediated by a change in cell
deformability. Subsequent migration may be mediated through the
release of chemotactic factors such as C5a, LTB4 (Sibille and Reynolds,
1990) and IL-8 (Kunkel et al., 1991). Macrophages are increased in number
at the site of development of centrilobular emphysema (Niewoehner et
al., 1974) and cigarette smoke can cause macrophages to release
chemotactic factors for neutrophils (Hunninghake et al., 1980). Total
glutathione concentration is correlated with neutrophil numbers, levels
of myeloperoxidase and elastase and chemotactic activity for neutrophils
in BALF (Linden et al., 1989).
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I performed bronchoscopy and BAL in unpaired smokers and non-
smokers. The smokers were asked to either abstain for 12 hours as above
or to follow the acute smoking protocol. The total number of cells was
significantly increased in the chronic smoking group and elevated 6.5 fold
in the acute smoking group although this was not a statistically
significant increase. These increases were largely due to increased
numbers of macrophages although there were no changes in the
percentage of macrophages in BALF. There was a significant increase in
the percentage and number of neutrophils in BALF in the acute smoking
group with no difference between the chronic smoking group and non-
smokers. There was no correlation however between either the total
number of cells or the number and percentage of neutrophils in BALF
and 99nrrc_p)TPA clearance. It is however possible that acute cigarette
smoking may induce a change in inflammatory leucocytes which makes
them less likely to be sampled by BAL. The plasma membrane fluidity of
rat alveolar macrophages is significantly reduced by exposure to cigarette
smoke beginning as early as 2 weeks (Hannan et al., 1989) and exposure of
monolayers of bovine bronchial epithelial cells to cigarette smoke
significantly increases adherence of both cocultured neutrophils and
mononuclear cells (Robbins et al., 1992).
Previous studies have either not controlled the smoking of the study
subjects or have not looked at the acute effects of cigarette smoking. This
study has done both and demonstrates that influx of neutrophils into the
airspaces occurs within 12 hours of smoking. The effect is not the result of
changes in respiratory function measured, BAL return, cell viability or
differences in the smoking habit or duration of the 2 groups of smokers.
Although I did not measure small airways function it is unlikely that the
increased numbers of neutrophils found in the BALF of acute smokers
was a sampling artefact resulting from acute small airways constriction as
acute cigarette smoking also causes sequestration of neutrophils in the
pulmonary vasculature in humans (MacNee et al., 1989).
An imbalance between oxidants and anti-oxidants has been proposed in
the pathogenesis of COPD (Taylor et al., 1986) and there is increasing
evidence of the importance of an oxidant anti-oxidant imbalance in the
lungs in other diseases such as asthma, IPF, ARDS and cystic fibrosis
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(Cross et al, 1994a). Cigarette smoke is the most important factor in the
aetiology of COPD (United States Department of Health and Human
Services, 1984) and contains 1CF6 free radicals per puff (Janoff et al., 1987).
In cigarette smokers increased numbers of inflammatory cells are found
in the interstitium and BALF and macrophages accumulate around the
junction between the terminal bronchiole and acinus (Niewoehner et al.,
1974). These cells are capable of releasing increased amounts of 02~ and
thus contribute further to the increased oxidant burden found in the
airspaces of cigarette smokers (Hoidal et al., 1981). Cigarette smoke
condensate has been shown to decrease epithelial cell adherence and
increase detachment and lysis in a human type II alveolar epithelial cell
line (A549) (Lannan et al., 1994).
In keeping with previous studies I found 02*~ production from
inflammatory BAL leucocytes was significantly increased in smokers
although I found no difference between chronic and acute smoking in
this respect. Acute cigarette smoke exposure of neutrophils obtained from
the peritoneal cavity of rats has been shown to damage the respiratory
burst, this effect probably being initiated by the generation of 02~ with
OH- generation a subsequent injurious factor (Tsuchiya, Suzuki et al.,
1992, Tsuchiya, Thompson et al., 1992).
Increased levels of products of lipid peroxidation have been reported in
the plasma and lung tissue of smokers (Petruzzelli et al., 1990, Duthie et
al., 1991, Bridges et al, 1993, Morrow et al., 1995, Rahman et al., 1996). I was
able to confirm this in plasma by the measurement of TBARS. In one
study acute smoking of 3 cigarettes over 3 minutes had no effect on the
levels of circulating products of lipid peroxidation but 2 weeks abstinence
with compliance checked by measurement of urinary nicotine and
cotinine resulted in a significant reduction (Morrow et al., 1995).
Similarly I found no difference between acute and chronic smokers in
their levels of TBARS and no reduction after 12 hours abstinence. Frei
and colleagues found that exposure of plasma to the gas phase of cigarette
smoke induced lipid peroxidation once endogenous ascorbic acid had
been oxidised completely. In addition cigarette smoke exposure caused
oxidation of plasma PrSSG and albumin-bound bilirubin (Frei et al.,
1991). Cross and colleagues also found whole cigarette smoke induced
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lipid peroxidation in plasma in vitro to be inhibited by ascorbic acid
(Cross et al., 1993). There are no previous reports of the effects of acute
cigarette smoking on the levels of products of lipid peroxidation in BALF
or ELF. The numbers I studied were too small to reach statistical
significance but there appears to be a pattern suggesting that not only are
TBARS increased in the BALF of cigarette smokers but that they are
further increased by acute cigarette smoking. The same pattern was
observed for ELF.
Anti-oxidant capacity is reduced in the plasma in chronic smokers (Taylor
et al., 1986). Measured in serum as the percentage reduction of auto-
oxidation of ox-brain homogenate it is decreased in cigarette smokers
(Galdston et al., 1984). There is a strong relationship between a deficiency
in the anti-oxidant capacity of plasma and a family history of lung disease
(Taylor et al., 1986). I have demonstrated that not only is the anti-oxidant
capacity of plasma significantly reduced in chronic cigarette smokers but
that the level following acute cigarette smoking is approximately two
thirds of that in the chronic smoking group. Conversely in BALF the
anti-oxidant capacity is significantly elevated in both the smoking groups
with no difference between them. This may be due to the elevated
airspace epithelial permeability found in cigarette smokers allowing
influx of anti-oxidant molecules into the airspaces from the vascular
space and the interstitium of the lung. One however might have expected
a further increase following acute smoking if this were the case, in
association with the further increase seen in epithelial permeability after
acute cigarette smoking. In addition there was no correlation between
99mpc_p)TPA lUng clearance and BALF or ELF anti-oxidant capacity. On
the other hand the increase in anti-oxidant capacity in the airspaces of
chronic smokers may already have been maximal. Again the pattern was
repeated in ELF but the changes did not reach statistical significance.
Cigarette smoke condensate increases epithelial permeability in vitro in
epithelial cell monolayers and in vivo in rat lungs in association with
changes in the homeostasis of the anti-oxidant GSFt (Li et al., 1994). A
dose and time dependent reduction in intracellular GSH and formation
of GSH conjugates occurs without elevation of GSSG (Rahman et al,
1995). Cigarette smokers have increased levels of GSH in ELF (800jUm)
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compared to non-smokers (400^m) (Cantin et al., 1987). I have confirmed
these levels not only in BALF and ELF but have also demonstrated the
same pattern in mixed BAL leucocytes. These increases were abolished by
acute cigarette smoking reinforcing the hypothesis that the repeated acute
insult from cigarette smoking is important in disturbing the oxidant anti¬
oxidant balance in the lungs.
Other anti-oxidants are altered in smokers. In serum, ascorbic acid,
vitamin E, fl-carotene and selenium are decreased (Pelletier, 1970, Chow
et al., 1986, Bridges et al., 1990, Duthie et al., 1991, Van Antwerpen et al.,
1993). In leucocytes, vitamin E and ascorbic acid are decreased (Barton and
Roath, 1976, Hemila et al., 1984, Theron et al., 1990). In erythrocytes GSH,
SOD and catalase are enhanced (Toth et al., 1986). In BALF, catalase
activity (Greening et al., 1985) and ascorbic acid are increased (Bui et al.,
1992) and vitamin E reduced (Pacht et al., 1986). In alveolar macrophages
ascorbic acid is increased (McGowan et al., 1984). Increased activities of
SOD and catalase have been demonstrated in the alveolar macrophages of
young smokers (McCusker and Hoidal, 1990). However in elderly
smokers SOD, glutathione-S-transferase (GST) and GPX activities are
reduced (Kondo et al., 1994).
Thus I have demonstrated that the epithelial permeability found in
cigarette smokers is an acute effect. Influx of neutrophils into the
airspaces occurred following acute cigarette smoking. Alterations in the
oxidant anti-oxidant balance in the plasma and in the airspaces were
found, resulting in increased oxidant stress, particularly following acute
smoking. No relationship was found between airspace epithelial
permeability and any of the variables studied but further investigation,
including non-smokers in both the 99mxc_[)TPA lung clearance and the
bronchoscopy and BAL studies, may yield further important results.
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CHAPTER 5. EPITHELIAL PERMEABILITY, INFLAMMATION,
OXIDANT STATUS AND THE CYTOSKELETON IN AIRSPACE
EPITHELIUM FOLLOWING EXPOSURE TO OZONE IN VIVO AND IN
VITRO.
5.1. INTRODUCTION.
Ozone is one of the constituents of photochemical pollution. Such
pollution results in part from the increasing number of motor vehicles in
use. NOx react with VOC's and sunlight to produce ozone and a range of
other oxidants. Concerns have been raised over this man-made ozone in
the lower atmosphere and its possible adverse effects on health, in
particular its possible role in the increased incidence of asthma and the
association of higher levels with increased admissions due to asthma.
Few measurements were made prior to 1970 but it would seem likely that
prior to this levels were lower (Department of Health, 1991). Since then
the evidence does not suggest any general upward trend (Lung and
Asthma Information Agency, 1993/5).
Like cigarette smoke, ozone has been shown to produce increased
respiratory epithelial permeability in vivo in humans (Kehrl et al, 1987,
Koren et al., 1989, Devlin et al., 1991), in animals (Bhalla and Crocker,
1986, Stutts and Bromberg, 1987, Bhalla et ah, 1990, Bhalla and Young,
1992, Kleeberger and Hudak, 1992, Nishikawa et ah, 1992) and in vitro
(Cheek et ah, 1994, Yu et ah, 1994). Ozone also produces influx of
neutrophils into the airspaces and evidence of inflammation in normal
non-smokers (Koren et ah, 1989, Devlin et ah, 1991, Koren et ah, 1991,
Schelegle et ah, 1991) and in asthmatics (Basha et ah, 1994). Neutrophil
influx has also been demonstrated in animal studies (Bhalla and Young,
1992, Hyde et ah, 1992, Kleeberger and Hudak, 1992, Young and Bhalla,
1992).
Ozone has a standard redox potential of +2.07V and is therefore the
second most powerful oxidant known behind fluorine. It is believed to
cause damage to biological tissues either by direct reaction or through the
formation of free radicals and reactive intermediates or by both
mechanisms. Peroxidation of membrane lipids is thought to be a most
important mechanism of ozone injury with oxidation of functional
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groups and loss of activity of biomolecules including enzymes. As
mentioned above alteration of membrane permeability occurs and there
is induction of inflammation and initiation of secondary processes.
The GSH redox cycle is thought to play a crucial role in anti-oxidant
defence against lipid peroxides and other damaging related oxygenated
intermediates and can promote the repair of injured cells and tissues
enabling the lung to withstand further injury (Mustafa, 1990).
Intracellular GSH is depleted by ozone exposure in vivo in animal
studies (Mountain, 1963, De Lucia et al., 1975, Mustafa, 1990) and in vitro
(Freeman and Mudd, 1981, Van der Zee et al., 1987). Depletion of other
anti-oxidants such as uric acid and ascorbic acid in BALF from humans,
exposed in vitro to ozone, has also been demonstrated (Mudway et al.,
1994).
As with cigarette smoke the lungs may be rendered more susceptible to
inhaled agents such as allergens, viruses and pollutants. This may in part
explain the observation of increased susceptibility to allergen produced by
ozone in asthmatic subjects (Molfino et al., 1991). Regulation of the
oxidant anti-oxidant balance, and in particular GSH may play an
important role in maintaining the integrity of the respiratory epithelium.
Bhalla and colleagues have suggested that this may involve the
cytoskeleton (Bhalla et al., 1990).
The aim of this study was to investigate epithelial permeability,
inflammation and oxidant anti-oxidant balance in the airspaces of
healthy non-smokers exposed to ozone and the effect of ozone on
epithelial permeability, GSH levels and the cytoskeleton in A549 cell
monolayers in culture. Ozone is a pure oxidant unlike cigarette smoke
which contains 1016 free radicals in each puff, one of which is ozone itself
(Janoff et al., 1987). I therefore chose ozone as a model for the oxidant
effects of cigarette smoke on the respiratory epithelium in vivo and in
vitro,, in particular the acute effects in healthy non-smokers




Fifteen healthy non-smokers (M:F 12:3) between 21 and 50 years of age
were recruited. Ten subjects were studied on 2 occasions. No subjects had
any significant medical problems nor any history of respiratory infection
within 6 weeks of the study.
5.2.2. Study design.
Five studies involved exposure to filtered air (FA). Of the remaining 20,
10 were to ozone lOOppb and 10 to 400ppb for 1 hour during a standard
exercise protocol (alternate 15 minutes exercise and rest) on a bicycle
ergometer (Figure 2.9) at an inspiratory minute ventilation (Vj) of 40
lmin~l as assessed in a previous study breathing FA. COFIb was measured
prior to recruitment and on each visit prior to study to confirm the
history of non-smoking. Spirometry was performed before and either
immediately, 1 or 6 hours after exposure. Cardiac monitoring and oxygen
saturation measurements were performed throughout each exposure.
The clearance rate of 99mpc_p>ppA from the lungs was measured to assess
airspace epithelial permeability. Bronchoscopy and BAL were performed
in each subject at least 2 weeks apart from the 99mTc_p)TpA study. Ten
studies were performed 1 hour after ozone exposure and 10, 6 hours after
(5 at lOOppb and 5 at 400ppb).
5.2.3. Stability of 99mTc_DTPA
Thin layer chromatography of the residual 99mpc_p>ppA jn the nebuliser
and urine was performed in 2 subjects, 1 hour after FA and 1 hour after
400ppb ozone. There was 0% (nebuliser) and 0.4% (urine) dissociation
into DTPA and free pertechnetate in the former and 0% and 1.1%
dissociation respectively in the latter (Zimmer and Pavel, 1977).
5.2.4. In vitro studies.
Exposure of A549 cells to ozone lOOOppb for 1 hour in vitro and
measurement of epithelial permeability, GSH, PrSSG and cytoskeletal
assessment were performed as described in Chapter 2.7.2. and 2.8.
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5.2.5. Ethics.
Ethical permission was obtained from the local medical ethics committee
and all patients gave informed written consent.
5.2.6. Statistics.
5.2.6.i. In vivo.
The effects of 0, 100 and 400ppb ozone on spirometry prior to 99mpc_
DTPA lung clearance scanning and prior to bronchoscopy and BAL and
the effects on 99mpc_y)rppA lung clearance, BAL characteristics, BALF and
plasma albumin, ELF volume, Q?-" release, BALF and ELF lipid
peroxidation and TEAC, and GSH and GSSG in cells, BALF and ELF were
compared by one way ANOVA with post hoc Scheffe test. These were
performed separately for the 1 hour and 6 hour studies. In the analysis of
the 6 hour studies the control data used as reference were the FA values
from the 1 hour study. Data from the 1 and 6 hour studies were compared
by independent t-test. 99nvpc-DTPA lung clearance for the right and left
lungs were compared by paired t-test. Pre and post values for lipid
peroxidation and TEAC at 0, 1 and 6 hours post exposure were compared
by paired t-test. GSFI and GSSG were analysed separately. Correlation was
performed by a 2 variable parametric analysis.
5.2.6.ii. In vitro.
Studies of monolayer permeability, thiols and the cytoskeleton were
analysed by two way ANOVA with independent variables of air or ozone
and experiment.
5.2.6.iii. Acknowledgement.
Statistical advice was given by Dr. TJ Peters, Senior Lecturer in Public
Health Medicine, Department of Social Medicine, University of Bristol,
Bristol. All calculations were performed on Statistica/Mac^M^ Release




5.3.1.i. Subject characteristics and spirometry (99myc_p)ypA study).
There were no significant differences between baseline spirometry or age
prior to 99nvrc_p)XPA lung clearance scanning or in RR during the
inhalation of the 99mpc_[)XPA between the 5 groups of subjects (Table
5.1). No significant effects of ozone on spirometry were seen immediately,
1 or 6 hours after exposure. The maximum fall in the mean FEVi of 0.41
was produced by 400ppb 1 hour after exposure (Figure 5.1). Subjects varied
greatly in their sensitivity to ozone the maximum fall of 40% occurring
in one subject unassociated with symptoms. Two subjects experienced a
feeling of inspiratory limitation. Ozone sensitive and ozone resistant
subjects have not been analysed separately because of the small numbers
in each group. FVC followed the same pattern with similar magnitude as
FEVi. There was a trend for the RR to be higher in the ozone exposed
groups although it did not reach statistical significance. This is as one
would expect as it has been well demonstrated that ozone decreases the
TV and thus increases the RR due to a limitation of inspiration perhaps
due to discomfort. This may be due to stimulation of non-myelinated C-
fibres possibly by PG's released during airway inflammation (Hazucha et
al, 1989).
5.3.1.ii. Spirometry (BAL study).
There was no significant difference in baseline FEVi prior to ozone
exposure in the BAL studies and during the course of these studies FEVi
followed the same pattern as above with a maximum fall of 0.41 with
400ppb but occurring immediately after exposure (Table 5.2). No
measurements were made 1 hour after exposure as patients were being
given premedication for the bronchoscopy at this point. As before none of
the changes reached statistical significance.
5.3.1.iii. 99mjc.p)jp^ lung clearance.
99mpc_p)'rp/\ lung clearance did not change significantly after exposure to
ozone at 100 or 400ppb either 1 or 6 hours after exposure regardless of
whether the right and left lungs were analysed separately (Table 5.3) or
together (Figure 5.2). The values are in keeping with those obtained for
the healthy non-smokers in Chapter 3 (84.6+6.2 minutes). There was a
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Table 5.1. Spirometry (mean±SE, n=5 except where indicated), respiratory rate
(RR) and age (+range) in healthy non-smoking subjects before (Pre) and after
(Post 0,1 and 6 hours) exposure to ozone 0, 100 or 400ppb for 1 hour during
intermittent exercise at Vi 401min'l. 99mxc-DTPA lung clearance scanning




















































































































































Pre Post Ohrs Post Ihr Post 6hrs
Time after ozone exposure
Figure 5.1. Spirometry (mean+SE, n=5) in healthy non-smoking subjects
before (Pre) and after (Post 0, 1 and 6 hours) exposure to ozone 0, 100 or
400ppb for 1 hour during intermittent exercise at Vj 40 lmin~l. The
values are taken from both the 99myc_p)TPA and bronchoalveolar lavage
studies.
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Pre Post 0 hrs Pre Post 0 hrs Post 6 hrs
Oppb FEVi (1) 4.0+0.3 4.1+0.3
%predicted 112.2+6.3 113.0+6.9
lOOppb FEVi 4.4+0.3 4.4+0.3 4.2+0.4 4.2+0.4 4.2+0.5
%predicted 109.6+2.8 111.3+2.7 113.4+2.6 114.5+2.9 113.3+3.5
400ppb FEVi 4.4+0.2 4.0+0.4 4.1+0.2 3.8+0.3 3.9+0.3
%predicted 104.6+3.3 95.7+8.9 107.0+6.5 100.1+10.5 103.5+8.4
Table 5.2. Spirometry (mean+SE, n=5) in healthy non-smoking subjects
before (Pre) and after (Post 0 and 6 hours) exposure to ozone 0, 100 or
400ppb for 1 hour during intermittent exercise at Vj 401min~l.
Bronchoscopy and bronchoalveolar lavage (BAL) were then performed



















































































































1 hour 6 hours
Time after ozone exposure
Figure 5.2. 99nrrc_]3TPA lung clearance (mean±SE, n=5) in healthy non¬
smoking subjects after (Post 1 and 6 hours) exposure to ozone 0, 100 or
400ppb for 1 hour during intermittent exercise at Vj of 401min_l. There
was no significant difference between 0, 100 and 400 ppb or between the 1
and 6 hour studies.
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trend towards increased airspace epithelial permeability 6 hours after
exposure of 400ppb. t50 tended to be higher for the left lung but this was
marginal and not statistically significant. All correlation coefficients for
the semi logarithmic time activity curves were greater than 0.92 and all
curves were observed to be monoexponential.
5.3.1.iv. Bronchoscopy and bronchoalveolar lavage.
There were no significant differences between the groups in BALF
recovery, total number of cells obtained or their viability (Table 5.4). The
total number of cells obtained was not expected to increase following
ozone (Koren et ah, 1989, Devlin et ah, 1991, Schelegle et ah, 1991).
Inhalation of ozone 400ppb resulted in an increased percentage (FA,
0.8±0.2%, 400ppb, 2.4+0.7, p<0.05) and number (FA, 0.11+0.04 xlO^ cells,
400ppb, 0.31+0.09, p<0.05) of neutrophils in BAL 6 hours after exposure.
There was a trend for lymphocytes to increase following 100 and 400ppb 1
hour after exposure but these changes were not statistically significant.
BALF albumin did not change significantly following ozone (Table 5.5)
although 1 hour after inhalation of 400ppb the concentration rose from
29.4+3.6 to 40.7±3.2^gml"l (Figure 5.3). After 6 hours it had fallen to
34.7±4.7jUgml"l. There were no changes in plasma albumin (Table 5.5).
There was a statistically significant effect of ozone overall (p<0.05) on ELF
volume (Table 5.5) but otherwise it followed the same pattern as BALF
albumin increasing from 1.10+0.11 to 1.64±0.11mls (p=0.057) 1 hour after
inhalation of 400ppb (Figure 5.4). Six hours after the level had fallen to
1.32±0.18mls.
02~ production by mixed BAL leucocytes was reduced in general
following inhalation of ozone at 1 or 6 hours after exposure (1 hour post,
p<0.05, 6 hours post, p<0.01). This was statistically significant following
lOOppb 1 hour after exposure (FA, 18.2±2.1nmol 2.5x10^ cells"! 120 mins~l,
lOOppb, 10.3+0.9, p<0.05) and 400ppb 6 hours after exposure (400ppb,
9.2+1.1, p<0.01) (Figure 5.5, Table 5.6). The value for the control group
exposed to FA was 4 times that of the non-smoking controls (4.60+1.00) in
Chapter 4. The major difference between the 2 groups of control non-






















































































































































































Table 5.5. Albumin levels in bronchoalveolar lavage fluid (BALF) and
plasma and volume of BALF and epithelial lining fluid (ELF) in healthy
non-smoking subjects (mean±SE, n=5) 1 and 6 hours after exposure to
ozone 0, 100 or 400ppb for 1 hour during intermittent exercise at Vj
401min~l. Overall there was a significant effect of ozone on ELF volume,
*p<0.05, at 1 hour post exposure and a trend towards a difference between








Figure 5.3. Bronchoalveolar lavage fluid (BALF) albumin in healthy non¬
smoking subjects after (Post 1 and 6 hours) exposure to ozone 0, 100 or







1 h r 6 h r
Time after ozone exposure
Figure 5.4. Epithelial lining fluid (ELF) volume in healthy non-smoking
subjects 1 and 6 hours after exposure to ozone 0, 100 or 400ppb for 1 hour
during intermittent exercise at Vj 401min~l. Overall there was a
significant effect of ozone on ELF volume, *p<0.05, at 1 hour post
exposure and a trend towards a difference between the levels of ozone





















1 hour 6 hours
Time after ozone exposure
Figure 5.5. Superoxide anion release from mixed bronchoalveolar lavage
leucocytes in healthy non-smoking subjects (mean±SE/ n=5) 1 and 6
hours after exposure to ozone 0, 100 or 400 ppb for 1 hour during
intermittent exercise at Vj 401min~l. *p<0.05, **p<0.01 versus Oppb lhour.
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Table 5.6. Superoxide anion release from mixed bronchoalveolar lavage
leucocytes in healthy non-smoking subjects (mean+SE, n=5) 1 and 6
hours after exposure to ozone 0, 100 or 400 ppb for 1 hour during
intermittent exercise at Vi 401min"l. *p<0.05/ **p<0.01 versus Oppb lhour.
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Increased C>2~ production following exercise has been described
previously (Boveris and Chance, 1973).
There were no significant differences in plasma products of lipid
peroxidation between pre and post exposure levels (Figure 5.6, Table 5.7).
Unlike C>2-~ production the control levels (1.47+0.06Jumoll"l) were very
similar to those in the non-smoking control group (1.51+0.21) in Chapter
4. There were no significant differences between the groups for lipid
peroxidation in BALF (Figure 5.7, Table 5.8). The control levels
(0.30+0.Oljimol"!) were considerably higher than those in the non-
smokers (0.05+0.05) in Chapter 4. In ELF there was a significant reduction
both 1 and 6 hours following 400ppb (1 hour post, 34.4+1.4,umol~l, p<0.05,
6 hours post, 44.4+4.2, p<0.05) compared to the control group (49.9+5.2)
(Figure 5.8, Table 5.8). The control values were 7.5 times higher than the
non-smoking values (6.56+6.56) in Chapter 4. The control values are in
fact higher than those in the acute smoking group (38.8+17.1).
Plasma anti-oxidant capacity showed no clinically relevant changes
following ozone exposure compared to the pre exposure values although
the slight increase from 1.20+0.18 to 1.24±0.17mmol 1~1 1 hour following
400ppb was statistically significant (Figure 5.9, Table 5.9). There was no
general trend to support the validity of this change. The control values
pre exposure (0.98±0.13mmol 1~1) are somewhat less than those in the
control group (1.31+0.10) in Chapter 4. Anti-oxidant capacity was not
altered significantly in BALF (Figure 5.10, Table 5.10) or ELF (Figure 5.11,
Table 5.10) by inhalation of ozone at 100 or 400ppb either 1 or 6 hours after
exposure. Control levels (BALF, 7.9+1.1, ELF, 1356±288jumol 1~1) were
similar to those in Chapter 4 (BALF, 8.2+1.6, ELF, 1160+230).
GSH in mixed BAL leucocytes (Figure 5.12, Table 5.11), BALF (Figure 5.13,
Table 5.11) or ELF (Figure 5.14, Table 5.11) did not change following
inhalation of ozone at 100 or 400ppb either 1 or 6 hours after exposure
although there was a trend in cells, BALF and ELF for GSH to decrease 6
hours after 400ppb ozone The control levels (Cells, 1.54±0.57nmol 10^
cells'l, BALF, 1.04+O.ll^M, ELF, 177.0+36.lj/M) were lower than those in
Chapter 4 (Cells, 4.65+1.68, BALF, 2.26+0.73, ELF, 353.7+125.3). There were
no significant changes in GSSG in cells, BALF or ELF following ozone.
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Ohrlhr . Ohr1hr6hr . 0hr1hr6hr
Oppb 1OOppb 400ppb
Time after ozone exposure
Figure 5.6. Products of lipid peroxidation in plasma in healthy non¬
smoking subjects (mean+SE, n=5, n=10) before and 0, 1 and 6 hours after












































































1 hour 6 hours
Time after ozone exposure
Figure 5.7. Products of lipid peroxidation in bronchoalveolar lavage fluid
(BALF) in healthy non-smoking subjects (mean+SE, n=5) 1 and 6 hours
after exposure to ozone 0, 100 or 400ppb for 1 hour during intermittent
exercise at Vj 401min~T
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Ozone Time after ozone exposure
1 hour 6 hours
Oppb BALF jimol l"1 0.30+0.01
ELF 49.9+5.2
lOOppb BALF 0.28+0.01 0.30+0.01
ELF 57.8+7.8 75.3+12.3
400ppb BALF 0.29+0.01 0.28+0.005
ELF 34.4+1.4* 44.4+4.2*
Table 5.8. Products of lipid peroxidation in bronchoalveolar lavage fluid
(BALF) and epithelial lining fluid (ELF) in healthy non-smoking subjects
(mean±SE, n=5) 1 and 6 hours after exposure to ozone 0, 100 or 400ppb for
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Figure 5.8. Products of lipid peroxidation in epithelial lining fluid (ELF)
in healthy non-smoking subjects (mean+SE, n=5) 1 and 6 hours after
exposure to ozone 0, 100 or 400ppb for 1 hour during intermittent exercise
at Vi 401min-l. *p<0.05 v lOOppb.
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Ohrlhr . Ohr1hr6hr . OhrlhrShr .
Oppb iOOppb 400ppb
Time after ozone exposure
Figure 5.9. Trolox equivalent anti-oxidant capacity (TEAC) in plasma in
healthy non-smoking subjects (mean+SE, n=5) before and 0, 1 and 6 hours
after exposure to ozone 0, 100 or 400ppb for 1 hour during intermittent














































































1 hour 6 hours
Time after ozone exposure
Figure 5.10. Trolox equivalent anti-oxidant capacity (TEAC) in
bronchoalveolar lavage fluid (BALF) in healthy non-smoking subjects
(mean+SE, n=5) 1 and 6 hours after exposure to ozone 0, 100 or 400ppb for
1 hour during intermittent exercise at Vj 401min~l.
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Ozone Time after ozone exposure
1 hour 6 hours
Oppb BALF fimol l"1 7.90+1.10
ELF 1356±288
lOOppb BALF 6.90+1.17 5.00+0.75
ELF 1546+470 1349+458
400ppb BALF 9.20+1.70 6.05+1.10
LT,F 1049+161 931+165
Table 5.10. Trolox equivalent anti-oxidant capacity in bronchoalveolar
lavage fluid (BALF) and epithelial lining fluid (ELF) in healthy non¬
smoking subjects (mean+SE, n=5) 1 and 6 hours after exposure to ozone 0,











1 hour 6 hours
Time after ozone exposure
Figure 5.11. Trolox equivalent anti-oxidant capacity (TEAC) in epithelial
lining fluid (ELF) in healthy non-smoking subjects (mean±SE, n=5) 1 and
6 hours after exposure to ozone 0, 100 or 400ppb for 1 hour during






































1 hour 6 hours
Time after ozone exposure
Figure 5.12. Glutathione (reduced GSH, oxidised GSSG) in mixed
bronchoalveolar lavage leucocytes in healthy non-smoking subjects
(mean+SE, n=5, n=4 where indicated) 1 and 6 hours after exposure to















































































































































1 hour 6 hours
Time after ozone exposure
Figure 5.13. Glutathione (reduced GSH, oxidised GSSG) in
bronchoalveolar lavage fluid in healthy non-smoking subjects (mean±SE,
n=5) 1 and 6 hours after exposure to ozone 0, 100 or 400ppb for 1 hour



























Time after ozone exposure
Figure 5.14. Glutathione (reduced GSH, oxidised GSSG) in epithelial
lining fluid in healthy non-smoking subjects (mean±SE, n=5) 1 and 6
hours after exposure to ozone 0, 100 or 400ppb for 1 hour during
intermittent exercise at Vj 401min"l.
151
The levels were close to the limit of detection of the assay.
There were no correlations between 99myc_]3rypy\ clearance and any of
the variables measured in particular the percentage or number of
neutrophils, BALF albumin, ELF volume, 02-~ production or products of
lipid peroxidation in ELF (Table 5.12).
53.2. In vitro.
Epithelial permeability, intracellular and extracellular thiols and
cytoskeletal study results in A549 cells in vitro are given in Table 5.13.
Exposure of monolayers of A549 cells to ozone lOOOppb for 1 hour
produced increased epithelial monolayer permeability regardless of
whether 125j bound to BSA and free (FA, 0.83+0.10%, Ozone, 1.07+0.11,
p<0.05) or only bound 125j 0.14+0.02, Ozone, 0.22+0.04, p<0.05) was
measured (Figure 5.15). This was due to focal cell loss as demonstrated in
Figure 5.16. These changes were abolished by the presence of medium
covering the monolayer during exposure. The level of GSH measured in
the cell medium increased significantly (FA, 0.12+0.03, Ozone, 0.28+0.04,
p<0.001) indicating export of intracellular GSF1 (Figure 5.17). Although
measured as total glutathione it is likely that the form exported was GSSG
(Deneke and Fanburg, 1989), this form being toxic to cells (Deneke and
Fanburg, 1989). There was no change in the intracellular concentration of
GSSG, although as above the measurement was at the limit of detection
of the assay, but there was a marked and statistically significant increase
in the intracellular concentration of PrSSG (FA, 0.28±0.02nmoles 10^
cells'l, Ozone, 0.66+0.06, p<0.001) (Figure 5.17). There was no difference in
cell viability between the cells exposed to FA (78.3+3.8%) and ozone
(79.5+4.1). These changes were associated with a significant reduction in
the percentage of cells containing normal cytoskeleton (FA, 60.6+3.2%,
Ozone, 28.3+4.0, p<0.001) (Figure 5.18). Normal and disrupted A549 cell
cytoskeleton are shown in Figure 5.19.
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Table 5.12. No significant correlations were found between t50 and age,
spirometry, bronchoalveolar lavage characteristics and differential or oxidant
and anti-oxidant measures. Studies were performed in healthy non-smoking
subjects before and 0, 1 and 6 hours after exposure to ozone 0, 100 or 400ppb
for 1 hour during intermittent exercise at Vi 401min~l. For spirometry, post
exposure, the 1 and 6 hour data were combined (Post 1, 6 hrs) and for plasma
lipid peroxidation and Trolox equivalent anti-oxidant capacity (TEAC) post
exposure the 0 and 6 hour data were combined (Post 0, 6 hrs). BALF-































































































































































































































































































































Total Iodine Bound Iodine
Figure 5.15. Epithelial permeability, assessed by the passage of 125j_bovine
serum albumin, in monolayers of A549 cells in vitro (mean±SE, n=7)
following air or ozone lOOOppb for 1 hour. Epithelial permeability is
expressed as a percentage of both the total and bound 125j activity in the
well with reference to standard aliquots of 125j_BgA *p<0.05, Air v
Ozone.
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Figure 5.16. A549 cell monolayers invitro following exposure to air (top
plate) or ozone lOOOppb (bottom plate) for 1 hour demonstrating focal cell
loss following ozone exposure.
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Figure 5.17. Intracellular and extracellular thiols in A549 cells in vitro
(mean±SE, n=6) following air or ozone lOOOppb for 1 hour. GSH-reduced
glutathione, GSSG-oxidized glutathione, PrSSG-protein mixed













Figure 5.18. Cytoskeletal assessment in A549 cells in vitro (mean+SE, n=4)
following air or ozone lOOOppb for 1 hour. The number of cells with
normal cytoskeleton is expressed as a percentage. ***p<0.001, Air v
Ozone.
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Figure 5.19. A549 cells in vitro following air (top plate) or ozone lOOOppb
(bottom plate) for 1 hour. Ozone exposure produced significant
disruption of the cell cytoskeleton.
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5.4.DISCUSSION.
Like cigarette smoke, ozone has been shown to produce increased
respiratory epithelial permeability. In healthy non-smoking males
exposed to 400ppb ozone for 2 hours during intermittent high intensity
exercise [expiratory minute ventilation (Ve) 66.81min~l] 7 out of 8 showed
increased 99nrrc_E)TPA lung clearance (Kehrl et al., 1987). In rats exposed
to 0.8ppm ozone for 2 hours ^m-pc-DTPA transfer across the tracheal
epithelium increased 2 fold and that of 125j_bsA also increased but to a
lesser degree. In ozone exposed rats the tracer HRP and 125j_bsa both
localised in the intercellular spaces between epithelial cells, throughout
their length, with most at the basement membrane and in endocytic
vesicles in all parts of the epithelial cells. HRP endocytic vesicles were
seen to fuse with the cell membrane through a short stalk and their
number and area increased significantly in both non-ciliated cells without
secretory granules and ciliated cells. However neither HRP nor 125j_BSA
were seen in tight junctions. In air exposed animals HRP was only seen
on the luminal cell surface and in endocytic vesicles (Bhalla and Crocker,
1986).
Oxidative stress induced by menadione in normal and cancer cells has
been shown to produce cell membrane blebbing with a reduction in the
amount of actin and PrSSG. Formation of high molecular weight
aggregates occurred due to oxidative cross linking of actin which contains
SH groups. All these changes were prevented by dithiothreitol (Bellomo
et al., 1990). The cytoskeleton therefore may also be a potential target for
ozone. Bhalla and colleagues produced permeability to 99mpc_p)rpp/\ anc[
125j_bSA in a main stem bronchus in rats exposed to ozone 0.8ppm for 2
hours and after in vivo treatment with cytochalasin D, which causes actin
rich microfilament destabilisation. However there was no increase in
permeability with vinblastine alone, which causes microtubule
depolymerisation, although it did produce a slightly greater increase in
permeability in combination with ozone than did ozone alone. When
cytochalasin and vinblastine treatment were combined there was a
synergistic effect on bronchoalveolar permeability suggesting that both
microfilamentous and microtubular cytoskeletal elements do in fact
participate in maintaining the integrity of the bronchoalveolar
epithelium (Bhalla et al., 1990).
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In guinea pigs exposed to ozone lppm for 3 hours there was a 45%
increase in potential difference and a 41% increase in short circuit current
across tracheal epithelium. In both exposed and control animals short
circuit current was equivalent to net 22^'a absorption but in the exposed
group was disproportionately more sensitive to the specific Na+ channel
blocker amiloride (Ozone 44% v Control 13%) (Stutts and Bromberg 1987).
This increase in active ion transport was present for up to 3 days after a
single exposure (Bromberg et al., 1991). It was concluded that the early
effect of ozone is to increase the density or open time of Na+ channels or
to increase the Na+ pump activity leading to a gradient for Na+ entry.
Increased permeability of the trachea to water soluble molecules also
occurred after ozone exposure when measured in vivo and HRP was
visualised in intercellular spaces (Bromberg et al., 1991). This was no
longer demonstrable after the 4th daily exposure and did not occur when
permeability was measured in vitro after in vivo ozone exposure.
In guinea pigs, ozone lppm for 90 minutes produced an immediate
increase in tracheal vascular permeability, as measured by the passage of
intravenous Evan's Blue dye, in association with an immediate increase
in airway responsiveness to methacholine. The magnitude of the
changes, but not the duration, was increased by combination with 10 puffs
of cigarette smoke. When exposed for only 30 minutes to ozone or 5 puffs
of cigarette smoke singly, there were no effects although the combination
did produce an immediate increase in permeability and airway
responsiveness. Ten puffs of cigarette smoke singly did not increase
tracheal vascular permeability but did increase airway responsiveness
(Nishikawa et al., 1992).
In a study of rat primary culture type II alveolar epithelial cells a dose
dependent increase in monolayer permeability, as measured by a decrease
in resistance, occurred following ozone exposure (Cheek et al., 1994). In
confluent canine bronchial epithelial cells 0.2-0.8ppm ozone produced a
dose dependent increase in transcellular electrical resistance and
mannitol flux. The increase in epithelial permeability was partly
prevented by vitamins E and A and phalloidin which produces actin
polymerisation. The effect of 0.2 and 0.5ppm were decreasing by 18 hours
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post exposure but the effect of 0.8ppm was still increasing at this time
point (Yu et al., 1994).
The levels of ozone chosen for our study were felt to equate with the
levels one might find in the U.K. (lOOppb) and in the U.S. (400ppb),
particularly in the Los Angeles basin. The lower level has been shown to
produce inflammatory effects in the lungs (Devlin et al., 1991) and the
higher to produce airspace epithelial permeability (Kehrl et al., 1987).
Most studies to date have used ozone concentrations which are not
relevant to the U.K. and are in fact often higher than those encountered
in the U.S.. This is particularly the case when one considers the intense
level of exercise used in many studies in association with exposure to
ozone lasting several hours. It is probable that the concentration and
duration of ozone exposure used in our study were too low or too short
to result in increased epithelial permeability. However it is possible to
speculate that with larger numbers in the study there would have been a
statistically significant effect on epithelial permeability 6 hours after
exposure to 400ppb ozone.
There was a significant effect of ozone overall on ELF volume suggesting
an increase in epithelial permeability. There was however no significant
effect of ozone on BALF albumin another measure of epithelial
permeability. Both ELF volume and BALF albumin showed a trend
towards an increase 1 and 6 hours after exposure.
Koren and colleagues studied human volunteers exposed to 0.4ppm
ozone for 2 hours during intermittent exercise at Vp 351min~l (m^body
surface area)"l and performed BAL on 2 occasions, each subject acting as
their own control. There was no change in the total number of cells but
the percentage of neutrophils increased from 2.4±0.8 to 10.8±1.3
(mean+SE). This was associated with increases in protein, albumin and
IgG. Neutral protease also increased with elevated HNE, in BALF and in
neutrophils themselves. An increase was seen in plasminogen activator.
Inflammatory indicators such as fibronectin, PGE2 and C3a also increased
(Koren et al., 1989). In a further study BAL was performed 1 hour after
exposure to the same dose and duration of ozone at Ve 601min~l. The
percentage of neutrophils increased from 1.3+0.2 to 9.9+1.6 (mean+SE)
163
associated with increases in PGE2 and IL-6 (Koren et al., 1991). Schelegle
and colleagues exposed normal humans to 0.3ppm ozone on 3 separate
days for 1 hour at Ve 601min~l. A significant neutrophilia occurred with
onset at 1 hour and peak at 6 hours (Schelegle et al., 1991). Devlin and
colleagues exposed non-smokers to 80 or lOOppb for 6.6 hours with
intermittent exercise at Ve 401min~l and performed BAL 18 hours after
exposure. Both doses produced a neutrophilia and elevated levels of
PGE2, lactate dehydrogenase, IL-6 and decreased phagocytosis of yeast by
macrophages via complement-receptor. The lower dose was also
associated with elevated ai-Pi and the higher dose with elevated protein
and fibronectin (Devlin et al., 1991). Basha and colleagues studied non¬
smoking asthmatics and healthy volunteers exposed to ozone 0.2ppm
and FA for 6 hours with 30 minutes alternating exercise at 51min~l (1VC"
1) and 30 minutes rest. BAL was performed 18 hours after exposure.
There was a significant increase in the percentage and number of
neutrophils per ml of BALF in the asthmatics following ozone exposure
(12.2+1.0%, p<0.05, 45 116+16 260ml~% p<0.05) compared to the asthmatics
exposed to FA (1.6+0.6, 2 652+1 135) and to the control subjects exposed to
ozone (6.8+0.7, 14 402+1 416) and FA (1.0+0.3, 1 494+624). This was
associated with significantly greater increases in IL-8 and IL-6 (Basha et al.,
1994).
In my own studies I found, as many other groups have (Koren et al., 1989,
Devlin et al., 1991, Schelegle et al., 1991), that the total number of cells
recovered in BAL did not change. The percentage and number of
neutrophils increased 6 hours after the inhalation of 400ppb ozone. As in
the smoking study in Chapter 4 this was not the result of sampling as the
maximal reduction in airway calibre occurred immediately after exposure
in the BAL studies. Our data are thus in keeping with that of Schelegle
and colleagues where neutrophil influx into BAL peaked at 6 hours in
pooled BAL (Schelegle et al, 1991). In our study no increase in the
neutrophil content of BAL occurred 1 hour after exposure. Schelegle did
however find a significant increase at 1 hour in the first or proximal
aliquot of BAL. Had I not pooled the aliquots of BAL then it is possible
that I might also have seen neutrophil influx beginning at 1 hour.
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Neutrophils may contribute to epithelial permeability by the release of
oxidants and arachidonic acid metabolites. In Rhesus monkeys exposed to
0.96ppm ozone for 8 hours there was a strong relationship between
epithelial necrosis and emigration and retention of neutrophils at all
airway levels (Hyde et al., 1992). In rat trachea following 3 hours exposure
to 0.8ppm ozone permeability to ^^mTc-DTPA increased immediately,
peaked at 8 hours, and returned to the control level at 24 hours. The total
number of neutrophils in the interstitium increased at 12 hours and
appeared to pass from the vasculature to the interstitium at 8 hours
(Young and Bhalla, 1992). In a further study BAL protein, reflecting tissue
injury and increased permeability, increased immediately after exposure,
peaked at 8 hours, declined after 12 hours and returned to normal after 16
hours, at which point repair was felt to begin. Albumin, reflecting
permeability only, increased over 0 to 4 hours after exposure, peaked 8 to
16 hours after and declined after 20 to 24 hours although it was still raised
at this time. The persistent increase in permeability was thought to be due
to the inability of new cells to form tight junctions, this being a late event
occurring only in mature cells. Immediately after ozone exposure cell
viability fell to 85% compared to 92% in control cells. It recovered rapidly
and by 4 hours had risen to above 90% although it remained below that of
the control cells. This fall, presumably due to cell destruction, suggests a
rapid and direct toxic effect of ozone. The neutrophil count in alveolar
septae increased 3 fold at 4 hours, peaked at 8 hours and returned to
normal after 16 hours. It lagged behind the protein changes and coincided
with the changes in albumin suggesting that the neutrophil influx was a
consequence of the increased permeability. Morphological evidence of
cell injury was seen with thickening of alveolar septae and increased
parenchymal cellularity plus free cell accumulation. These changes began
to occur at 12 hours with a sharp increase at 16 hours which continued
through 20 and 24 hours. The time course of the morphological changes
was later than that of the functional impairment and therefore not a
direct measure of it. Variation was seen between animals in the time at
which the morphological changes began with 2 out of 6 animals showing
changes at 8 hours and 4 at 12 hours. Injury from ozone thus appeared to
stop functionally at 16 hours and permeability to continue until cells
matured sufficiently to form tight junctions (Bhalla and Young, 1992).
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It would seem likely therefore that ozone produces an initial direct injury
to cell membranes and possibly to macrophages, with increased
permeability, resulting in increased release of chemotactic stimuli for
neutrophils and thus an increase in their numbers. This secondary
inflammatory response will result in further injury and permeability.
However following a study of rats inhaling 0.2 to 0.8ppm ozone, for 7
hours daily and for up to 4 days, Donaldson and colleagues concluded
that epithelial injury by ozone at the concentrations used was likely to be
a direct effect of the ozone and not an indirect effect of inflammatory
leucocytes. They found an increase in neutrophils in BAL but no
stimulation of any measures of the ability of leucocytes to cause injury to
epithelial cells or extracellular matrix (Donaldson et al, 1993).
Ozone induced permeability in rats, exposed to 0.8ppm for 2 hours, was
inhibited by pretreatment with cyclophosphamide, FPL 55712 (an LTD4
antagonist) and indomethacin although LTB4 had no effect on
permeability. This may perhaps be explained by the short duration of the
effect of LTB4 despite being chemotactic for neutrophils and causing
neutrophil aggregation and degranulation (Bhalla et al., 1992). However
in mice exposed to 2ppm ozone for 3 hours, indomethacin, colchicine (a
chemotaxis inhibitor) and cyclophosphamide, in a dose sufficient to
produce granulocytopaenia, all resulted in a significant decrease in
neutrophil influx at 6 and 24 hours but did not attenuate the increase in
total protein in BALF induced by the ozone at either of these time points.
The cyclophosphamide also abolished any neutrophil response in
peripheral blood to ozone exposure (Kleeberger and Hudak, 1992).
Although this may have been the result of species differences the first
study employed 3 measures of epithelial permeability, 99mpc_p)xpA
clearance and both albumin and protein flux into BALF. Total protein, as
mentioned above, is an indicator of both tissue injury and epithelial
permeability and is thus less specific for the latter than the other 2
methods and this may explain the different results in the 2 studies.
Moreover it is well known that permeability of the alveolar capillary
membrane can occur in ARDS even in neutropenic patients (Sibille and
Reynolds, 1990).
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Neutrophils from ozone exposed rats have been shown to alter epithelial
resistance in vitro but only when stimulated with PMA or fMLP (Bhalla
et al., 1993). Neutrophils have a synergistic effect on ozone (lppm, 3
hours) induced airway epithelial injury when perfused in the isolated
perfused rat lung (Joad et al., 1993). The motility of neutrophils isolated
from peripheral blood in rats exposed to 0.8ppm ozone for 2 hours and
incubated with ARL-14 or primary culture type II cells is increased with
spontaneous redistribution of actin filaments and greater adherence of
the neutrophils to the epithelial cell lines. Actin caps formed at sites of
contact and EM showed prominent surface modifications at sites of
contact (Bhalla et al., 1993).
Ozone produces solubilisation of elastin and increases its susceptibility to
proteolysis by HNE, an effect which can be prevented by ascorbate, EDTA
and uric acid (Winters et al., 1994). Inactivation by ozone of ai-Pi in vitro
both in solution and in plasma and of bronchial leucocyte proteinase
inhibitor (BLPI) in solution has been demonstrated. No inactivation of
ai-Pi occurred however in blood plasma in non-smoking volunteers
exposed to 0.5ppm ozone for 4 hours on 2 consecutive days (Johnson,
1980, Johnson, 1987). However, if significant local inhibition of anti-
proteases in the microenvironment of the lung were to occur following
ozone exposure then susceptibility to protease mediated damage would
increase.
Ozone has a standard redox potential of +2.07V and is therefore the
second most powerful oxidant known next to fluorine. It is believed to
cause damage to biological tissues either by direct reaction or through the
formation of free radicals and reactive intermediates or by both
mechanisms. Oxidant stress causes a loss of control of calcium
distribution within the cell (Nicotera and Orrenius, 1987). Lipid
peroxidation chain reactions are initiated with oxidation of functional
groups and loss of activity of biomolecules including enzymes.
Peroxidation of membrane lipids is thought to be a most important
mechanism of ozone injury. Ozone, 02~ and OH- radicals are all capable
of reacting with polyunsaturated lipids (LH) producing lipid free radicals.
In the presence of molecular oxygen very reactive and toxic peroxy
radicals are generated. They react further with LH producing
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hydroperoxide and further lipid free radicals. Aldehydes may be the most
important damaging compounds generated (Department of Health, 1991).
Lipid peroxidation has been observed in red blood cells exposed to ozone
(Goldstein and Balchum, 1967). In vivo evidence of lipid peroxidation
has been found in lung tissue from ozone exposed animals including
conjugated dienes (Goldstein et al., 1969) and TBARS (mostly MDA)
(Chow and Tappel, 1972, Sagai et al., 1987). There are no such studies of
lipid peroxidation in BAL. In aqueous solution ozone decomposes to
form H2C>2, and 02~, OH- and hydroperoxyl (HO2) radicals and reacts
similarly with molecular oxygen (Mustafa, 1990). The types of free radicals
produced in vivo are not certain but those that are produced are non¬
selective and fast reacting.
Ozone inhalation in healthy non-smoking volunteers is an oxidant
model for acute cigarette smoking. Cigarette smoke contains a huge
number of oxidant species whereas ozone exposure involves the
inhalation of a single oxidant species. Studies of ozone may allow a
clearer determination of oxidant effects on the airspaces. Although there
have been a number of studies in humans on the effect of ozone
inhalation on cellularity and other indicators of inflammation in the
airspaces there is little if any data on the effect of ozone inhalation on the
oxidant status of the airspaces in humans.
I found that although the production of O2 •' was increased in the control
group, as a result of exercise, ozone inhalation produced a reduction in
02-" production, 1 hour after lOOppb and 6 hours after 400ppb. However
on reviewing the data it appears there is a general trend that both doses
produced essentially the same effect, at both time points, although all the
changes did not reach statistical significance. This effect of ozone is
supported by data from previous studies (Amoruso et al., 1981, Ryer-
Powder et al., 1986, Donaldson et al., 1993) and may be related to the loss
of activity of a cytochrome b558 (Ryer-Powder et al., 1986).
There is limited data on the effect of ozone inhalation on lipid
peroxidation in humans either in plasma, BALF or ELF. Dillard and
colleagues and Lovlin and colleagues found that products of lipid
peroxidation, exhaled pentane and plasma MDA respectively, were
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increased by exercise (Dillard et al., 1978, Lovlin et al., 1987). I found no
significant changes in plasma or BALF. In ELF and in BALF the control
levels were again very much higher than those from the smoking study.
In ELF there was a significant reduction in TBARS both 1 and 6 hours
after 400ppb ozone The reverse trend seen in BALF albumin and ELF
volume 1 and 6 hours after 400ppb raises the possibility that the decrease
in products of lipid peroxidation seen in ELF could therefore be related to
the anti-oxidant capacity of albumin or may be dilutional. It is interesting
to speculate that epithelial permeability may thus have a protective role
against oxidant stress.
Ozone causes oxidation of SH groups, amines, alcohol groups and
aldehydes and other functional groups in proteins, enzymes, nucleic
acids, membranes and other small and large biomolecules. This may alter
the redox status of cells and their metabolic functions (Mustafa, 1990).
Ozone oxidises SH, for example GSH and those found in proteins. The
GSH redox cycle is thought to play a crucial role in anti-oxidant defence
against lipid peroxides and other damaging related oxygenated
intermediates. Alveolar macrophages have high levels of intracellular
GSH approximately 5mM (Horton et al., 1987). Various enzymes for
example GR, GPx, catalase, SOD and key enzymes of the pentose-shunt
pathway (glucose-6-phosphate and 6-phosphogluconate dehydrogenases)
play an important role in the anti-oxidant defence of the lungs and can
promote the repair of injured cells and tissues enabling the lung to
withstand further injury (Mustafa, 1990).
In murine L929 fibroblasts, exposed to ozone, GSH depletion occurred
with an initial increase in GSSG. There was no increase in GSH or GSSG
in the buffer covering the cells which were exposed for 10 seconds every
30 seconds (Van der Zee et al., 1987). GSH in rat lung after exposure to
ozone 4ppm for 6 hours fell by 40% but was recoverable with NaBHj.
There was no change in GSSG but PrSSG formation occurred peaking at
24 hours post exposure and reducing by 48 hours (De Lucia et al., 1975). In
rats inhaling 0.8ppm ozone for 6 hours daily BAL was performed
immediately after exposure on day 1, 18 hours after this exposure and
after the exposures on days 3 and 7. GSH was elevated in cells after day 3
and in BALF after 7 days with no change in GSSG in cells or fluid. GPX
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increased in cells after day 3 and GR was elevated immediately after the
exposure on day 1 and after day 7 (Boehme et al., 1992). In rats exposed to
ozone long term GST, GPX and SOD all increased in a dose dependent
fashion although not all changed at all levels of the airways (Plopper et
al., 1994).
Other studies have shown that acute ozone exposure results in depletion
and oxidation of GSH (Mountain, 1963, Freeman and Mudd, 1981). SH
groups may be found at the active site of proteins, enzymes, coenzymes
and other biomolecules and thus oxidation can alter the function of these
molecules. Amino acids are another site of attack in proteins particularly
cysteine, which itself contains an SH group, methionine, tryptophan and
tyrosine (Mustafa, 1990). As mentioned above two examples of enzymes
inhibited by ozone are ai-Pi and BLPI (Johnson, 1980, Johnson, 1987).
I studied the total functional anti-oxidant capacity of plasma, BALF and
ELF following ozone exposure. No clinically relevant or statistically
significant changes occurred although the general trend in plasma was
towards a reduction. In BALF and ELF there was also no evidence of any
increase, as was seen in the smoking study with both acute and chronic
smoking.
Similarly no significant changes occurred in GSH or GSSG levels in
mixed BAL leucocytes, BALF or ELF. The data suggest a trend towards a
decrease 6 hours after 400ppb ozone. It is certainly clear that there was no
increase. The control values, not only for GSH, but also for TEAC, were
generally lower than in the smoking study. Viguie and colleagues found
that exercise was associated with a decrease in GSH and an increase in
GSSG in blood with no change in total glutathione. Levels returned to
baseline after 15 minutes of recovery (Viguie et al., 1993).
In vitro I found that exposure of A549 type II epithelial cell monolayers to
lOOOppb ozone for 1 hour produced focal cell loss. There was not
surprisingly a marked increase in permeability to 125j_ggA. I had hoped
to find a dose of ozone which would have produced epithelial
permeability without cell loss. Whilst some dissociation of the 125j fr0m
the BSA occurred with time in storage this did not alter the result as
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demonstrated by studies of both total ancj pgA bound 125j j found
evidence of oxidant stress in the cells. Although there was only a trend
towards a decrease in GSH intracellularly there was a significant increase
in PrSSG and in the medium bathing the cells there was a significant
increase in the level of GSH measured. As noted above the latter is likely
to represent the export of intracellular GSSG which is toxic to cells. In
cases where GSSG may accumulate it is either transported from the cells
or reacts with protein sulphydryls via a mixed disulphide reaction
(Deneke and Fanburg, 1989). Van der Zee and colleagues did find a
significant depletion of GSH in murine L929 fibroblasts exposed to ozone
with an initial increase in GSSG intracellularly although no GSH or
GSSG was detectable in the extracellular buffer (Van der Zee et ah, 1987).
They could not however rule out leakage as GSH and GSSG might both
be readily oxidised in the medium, particularly as they used PBS.
The percentage of cells in our study showing a normal cytoskeleton also
fell markedly. Disruption of the actin filaments occurred following ozone
exposure resulting in aggregation of the actin. Actin molecules contain
SH groups and our results are consistent with the study by Bellomo and
colleagues where oxidant stress produced high molecular weight
aggregates of oxidatively cross linked actin (Bellomo et ah, 1990).
Epithelial permeability induced by ozone in vitro can be prevented not
only by anti-oxidants but also by phalloidin which produces
polymerisation of actin (Yu et ah, 1994). Bhalla and colleagues have
shown that both microfilamentous and microtubular cytoskeletal
elements participate in maintaining the integrity of the bronchoalveolar
epithelium (Bhalla et ah, 1990) (Bhalla et ah, 1990).
Thus in summary I have shown an effect of the inhalation of ozone
400ppb for 1 hour on epithelial permeability during moderate
intermittent exercise. ELF volume increased significantly overall
although there were only trends towards an increase in 99mjc_p)ypy\
lung clearance and BALF albumin. There was a significant increase in the
percentage and number of neutrophils in BALF 6 hours after 400ppb
ozone. Despite this the levels of 02~ production from mixed BAL
leucocytes and products of lipid peroxidation in ELF decreased. This could
not be explained by any increase in either the total functional anti-oxidant
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capacity or the levels of GSH in either BALF, ELF or plasma. There was
therefore no evidence of increased oxidant stress accompanying the above
change in epithelial permeability and neutrophil influx into the
airspaces. This contrasts with the in vitro studies in which a higher
concentration of ozone was used. Focal cell loss and evidence of oxidant
stress were seen with disruption of the cell cytoskeleton.
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CHAPTER 6. SUMMARY.
In this thesis I have investigated the effects of cigarette smoke and ozone
on the respiratory epithelium in particular focussing on their oxidant
effects. Oxidants may be inhaled, as with cigarette smoke or ozone, or
released into the airspaces by inflammatory leucocytes. There is evidence
of an alteration in the oxidant anti-oxidant balance in many respiratory
conditions including COPD (Taylor et al., 1986, Cross et al., 1994a,
Rahman et al., 1996). The oxidant anti-oxidant balance is critically
important to the maintenance of normal cell function. The respiratory
epithelium acts as a barrier against inhaled material for example cigarette
smoke, pollutants such as ozone, bacteria, viruses and allergens and it
maintains the composition and volume of the RTLF's. Cigarette smoke is
the main aetiological agent in COPD and contains 1016 free radicals per
puff (Janoff et al., 1986). Ozone is the second most powerful oxidant
known. Both cigarette smoke and ozone have been shown to produce
airspace epithelial permeability (Jones et al., 1980, Kehrl et al., 1987). The
mechanism of these effects is not known although it has been proposed
that it is the repeated acute injury from cigarette smoking that results in
increased epithelial permeability (Hogg, 1983). The most likely site for the
increase in epithelial permeability produced by cigarette smoke is in the
distal terminal and respiratory bronchioles (Niewoehner et al., 1974,
Walker et al., 1982, Hogg, 1983). The effect of cigarette smoking on
epithelial permeability occurs within 3 days of starting smoking (Minty e t
al., 1984) and is rapidly reversible on stopping (Minty et al., 1981, Mason et
a I., 1983). Studies with cigarette smoke have shown passage of tracer
molecules through progressively disrupted tight junctions and through
both intercellular and cellular pathways (Simani et al., 1974, Boucher et
al., 1980, Burns et al., 1989). Studies with ozone have also shown passage
through intercellular and cellular pathways but this has not been
demonstrated through tight junctions (Bromberg et al., 1981, Bhalla and
Crocker, 1986).
The permeability of the respiratory epithelium can be studied by
following the passage of 99mpc_p)ppA from the lungs to the blood. My
initial studies compared 3 methods of 99nvpc_uppA clearance and
assessed their repeatability. Initial studies performed in the U.K.
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employed a correction for recirculating background activity (Jones et al.,
1980, Minty et al., 1981). An intravenous injection of 99nvfc_[yrpA was
given and the assumption made that this would equilibrate in a
background region in the same way as in the lungs. Background ROI's
have been used over the inter-renal region (Langford et al., 1986) and
over both shoulders (O'Doherty et al., 1985b). In North America studies
have used only the first 7-10 minutes of the clearance curve
(Rinderknecht et al., 1980, Mason et al., 1983) making the assumption that
during this period there is no recirculating background activity. A wide
range of normal values for t50, using uncorrected and corrected methods,
has been quoted in the literature [44.4-117.5 minutes] (Rinderknecht et al.,
1980, O'Doherty et al., 1985b, Langford et al., 1986). Although comparisons
between the uncorrected and corrected forms of the technique have been
performed (O'Doherty et al., 1985b, Langford et al., 1986) these have
compared analysis on the complete clearance curves. Not surprisingly it
was found that the uncorrected technique gave significantly higher
values. However this comparison is not one that reflects the practice of
the methods of analysis as given above. We therefore compared
uncorrected analysis on the first 7 minutes of the clearance curve with 2
methods of corrected analysis on the complete clearance curve pre
intravenous injection. No difference was found in the values obtained in
smokers although surprisingly the uncorrected analysis gave higher
values in non-smokers. There was no correlation between the
uncorrected t50 values and the correction factors for the background
corrected methods of analysis. There were no differences between the
values obtained at 2 separate visits with any of the 3 methods nor in their
repeatability. Having completed these studies I feel that a background
correction is necessary however, as it allows the analysis of any form of
curve, the nature of which cannot be predicted in advance. The inter-
renal background ROI is simple and rapid to apply and has been shown to
equate most closely, in terms of background correction, to the lungs
(Langford et al., 1986) and this method was therefore used for further
studies.
Previous human studies have not attempted to define the acute and the
chronic effects of smoking on epithelial permeability, inflammation and
oxidant status in the airspaces of chronic smokers. Fourteen chronic
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cigarette smokers underwent 99mjc_p)TPA iung scans after refraining
from smoking for 12 hours (chronic smoking group) or after continuing
to smoke until 1 hour before study (acute smoking group). ^nvjc.pyppA.
clearance was significantly increased in the chronic smoking group and
increased further and significantly after acute smoking. Each smoker also
underwent bronchoscopy and BAL after either chronic or acute smoking.
Seven healthy non-smokers were also studied. There was a trend towards
increased albumin concentration in BALF and increased ELF volume in
both smoking groups. Ozone exposure was also performed in 15 healthy
non-smokers as an acute oxidant model. Subjects inhaled FA or ozone
100 or 400ppb for 1 hour, during intermittent exercise at Vj 401min~l.
There was a significant overall increase in ELF volume. Inhalation of
400ppb resulted in a trend towards an increase in BALF albumin and ELF
volume 1 hour after exposure and an increase in c^mTc-DTPA clearance
6 hours after exposure. These data indicate that whilst increased epithelial
permeability is readily found in chronic cigarette smokers, it is an acute
phenomenon, supporting the proposal that it is the repeated acute insult
from cigarette smoke that is responsible (Hogg, 1983). I believe that small
numbers in the ozone studies prevented the above results reaching
statistical significance but overall they would appear to support the
hypothesis that increased epithelial permeability resulting from
inhalation of an oxidant is an acute phenomenon.
The absolute number of neutrophils in the airspaces has been
consistently raised in studies of smokers (Hunninghake and Crystal, 1983,
Nagai et al., 1988, McCrea et al., 1994). Various chemoattractants have
been proposed including C5a, LTB4 (Sibille and Reynolds, 1990) and IL-8
(Kunkel et al., 1991). There is sequestration of circulating neutrophils in
the pulmonary vasculature in cigarette smokers which is increased by
acute cigarette smoking (MacNee et al., 1989), mediated by a change in cell
deformability (Selby et al., 1991, Drost et al., 1993). Ozone inhalation has
been shown to cause neutrophil influx into the airspaces, beginning at 1
hour and peaking at 6 hours (Schelegle et al., 1991). In my studies the total
number of cells recovered in BAL was 11.4 fold greater in the chronic
smoking group and 6.5 fold greater in the acute smoking group compared
to the control non-smokers. The percentage and number of neutrophils
were significantly increased in the acute smoking group. Following ozone
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inhalation, although there was no increase in the total number of cells
obtained, the percentage and number of neutrophils increased 6 hours
after exposure to 400ppb. The increased number of neutrophils found in
the airspaces of cigarette smokers is therefore also an acute phenomenon.
The ozone studies support the hypothesis that oxidant inhalation results
in an acute inflammatory response in the lungs.
Q2~ release from mixed BAL leucocytes and products of lipid
peroxidation in plasma were significantly increased in both the chronic
and acute smoking groups compared to non-smokers. In BALF and ELF
products of lipid peroxidation doubled in the chronic smoking group and
increased 6 fold in the acute smoking group. TEAC was significantly
reduced in plasma in both groups with a trend towards a further
reduction in the acute smoking group. Conversely a significant and
similar increase in TEAC was seen in BALF (with the same trend in ELF)
in both smoking groups. GSH was increased 2 fold in mixed BAL
leucocytes, BALF and ELF in the chronic smoking group compared to
control non-smokers. This increase was abolished following acute
smoking. Ozone inhalation however, resulted in a significant reduction
in 02*" release from mixed BAL leucocytes and products of lipid
peroxidation in ELF, both 1 and 6 hours following 400ppb. The major
difference between the smoking and ozone studies was the exercise
performed by those in the latter which resulted in greatly increased
control values for C>2~ release and products of lipid peroxidation in the
group exposed to FA (Boveris and Chance, 1973, Dillard et al., 1978,
Lovlin et al., 1987). Products of lipid peroxidation in plasma and in BALF
were not altered by ozone inhalation, nor were TEAC in plasma, BALF or
ELF or GSH in mixed BAL leucocytes, BALF or ELF, although there was a
trend towards a decrease in GSH 6 hours following 400ppb. These studies
indicate that in smokers there is an increased oxidant burden which is
greatest following acute smoking, whilst conversely ozone inhalation
resulted in a reduction in some variables associated with oxidant stress.
In vitro studies of A549 cells exposed to ozone lOOOppb for 1 hour
produced epithelial monolayer permeability, due to focal cell loss, with
an increase in the concentration of protein thiols in the cells and export
of GSSG, and disruption of the cytoskeleton.
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In conclusion I present evidence that the increase in epithelial
permeability and neutrophil influx in the airspaces, produced by oxidant
inhalation are acute phenomena. No relationship was found between
them however, therefore further studies of the time course of oxidant
induced changes in indices of epithelial permeability and neutrophil
influx are required, to establish whether they are linked. In cigarette
smokers they were associated with an alteration in the balance between
oxidants and anti-oxidants, in the direction of increased oxidant stress,
particularly following acute cigarette smoking. The reduction in anti¬
oxidant capacity found in the plasma of cigarette smokers associated with
the increased level of anti-oxidant capacity in the airspaces suggests that
anti-oxidant molecules may be transferred from the plasma to ELF
following cigarette smoking perhaps as a result of increased epithelial
permeability. GSH is thought to be particularly important in protecting
the lungs from cigarette smoke (Rahman and MacNee, 1996). Although it
is elevated in the airspaces of chronic smokers this increase is
overwhelmed and abolished by acute cigarette smoking. The relative loss
of a major component of the overall anti-oxidant capacity in the airspaces
may be important factor in the acute effects of cigarette smoke on the
lungs. Animal and in vitro studies lend support to the hypothesis that a
reduction in GSH, resulting from cigarette smoke inhalation, may result
in epithelial permeability (Li et al.r 1994). I have demonstrated that both
are acute phenomena although further work is required to establish a
link between them in smokers. In contrast in vivo ozone exposure
resulted in a decrease in some measures of oxidant stress. Although the
overall picture was complicated by the effect of exercise, the fact that anti¬
oxidant levels were maintained suggests that either the dose of ozone
used was too low to affect them or that in healthy subjects they are not
overwhelmed by the inhalation of a powerful oxidant. Consequently
there was a less marked effect on epithelial permeability, despite the
potentially increased oxidant burden associated with the influx of
neutrophils into the airspaces. Studies combining ozone inhalation and
another acute inflammatory state, for example asthma, would
demonstrate whether the anti-oxidant defences in the lungs remain well
maintained in other such circumstances. It is clear from the in vitro
studies that ozone has the potential to produce increased oxidant stress in
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the respiratory epithelium and airspaces, with profoundly damaging
effects. In this era of increasing concern over the effects of environmental
pollution this indicates the need for futher research in this area.
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